BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tang Y, Liu J, Zhang D, Xu Z, Ji J, Wen C. Cytokine Storm in COVID-19: The Current Evidence and Treatment Strategies. Front Immunol. 2020;11:1708. [PMID: 32754163 DOI: 10.3389/fimmu.2020.01708] [Cited by in Crossref: 246] [Cited by in F6Publishing: 229] [Article Influence: 123.0] [Reference Citation Analysis]
Number Citing Articles
1 Shah A, Shah M, Kaidawala Z, Desphande R. Corona, Acute Ischemic Stroke, Malignant Cerebral Edema, and Hemo-adsorption: A Case Report. Indian Journal of Critical Care Medicine 2022;26:235-8. [DOI: 10.5005/jp-journals-10071-24116] [Reference Citation Analysis]
2 Sato K, Sinclair JE, Sadeghirad H, Fraser JF, Short KR, Kulasinghe A. Cardiovascular disease in SARS-CoV-2 infection. Clin Transl Immunology 2021;10:e1343. [PMID: 34512975 DOI: 10.1002/cti2.1343] [Reference Citation Analysis]
3 Archambault AS, Zaid Y, Rakotoarivelo V, Turcotte C, Doré É, Dubuc I, Martin C, Flamand O, Amar Y, Cheikh A, Fares H, El Hassani A, Tijani Y, Côté A, Laviolette M, Boilard É, Flamand L, Flamand N. High levels of eicosanoids and docosanoids in the lungs of intubated COVID-19 patients. FASEB J 2021;35:e21666. [PMID: 34033145 DOI: 10.1096/fj.202100540R] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
4 Sandor-Keri J, Benedek I, Polexa S, Benedek I. The Link between SARS-CoV-2 Infection, Inflammation and Hypercoagulability-Impact of Hemorheologic Alterations on Cardiovascular Mortality. J Clin Med 2021;10:3015. [PMID: 34300181 DOI: 10.3390/jcm10143015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Hamdy A, Leonardi A. Superantigens and SARS-CoV-2. Pathogens 2022;11:390. [DOI: 10.3390/pathogens11040390] [Reference Citation Analysis]
6 Sostin OV, Rajapakse P, Cruser B, Wakefield D, Cruser D, Petrini J. A matched cohort study of convalescent plasma therapy for COVID-19. J Clin Apher 2021;36:523-32. [PMID: 33616257 DOI: 10.1002/jca.21888] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
7 Samadder S. Immunopathological Changes in SARS-CoV-2 Critical and Non-critical Pneumonia Patients: A Systematic Review to Determine the Cause of Co-infection. Front Public Health 2020;8:544993. [PMID: 33634060 DOI: 10.3389/fpubh.2020.544993] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Berlansky S, Sallinger M, Grabmayr H, Humer C, Bernhard A, Fahrner M, Frischauf I. Calcium Signals during SARS-CoV-2 Infection: Assessing the Potential of Emerging Therapies. Cells 2022;11:253. [DOI: 10.3390/cells11020253] [Reference Citation Analysis]
9 Deschler S, Kager J, Erber J, Fricke L, Koyumdzhieva P, Georgieva A, Lahmer T, Wiessner JR, Voit F, Schneider J, Horstmann J, Iakoubov R, Treiber M, Winter C, Ruland J, Busch DH, Knolle PA, Protzer U, Spinner CD, Schmid RM, Quante M, Böttcher K. Mucosal-Associated Invariant T (MAIT) Cells Are Highly Activated and Functionally Impaired in COVID-19 Patients. Viruses 2021;13:241. [PMID: 33546489 DOI: 10.3390/v13020241] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
10 Desjarlais M, Wirth M, Lahaie I, Ruknudin P, Hardy P, Rivard A, Chemtob S. Nutraceutical Targeting of Inflammation-Modulating microRNAs in Severe Forms of COVID-19: A Novel Approach to Prevent the Cytokine Storm. Front Pharmacol 2020;11:602999. [PMID: 33362557 DOI: 10.3389/fphar.2020.602999] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
11 Ebrahimi M, Farhadian N, Amiri AR, Hataminia F, Soflaei SS, Karimi M. Evaluating the efficacy of extracted squalene from seed oil in the form of microemulsion for the treatment of COVID-19: A clinical study. J Med Virol 2021. [PMID: 34403141 DOI: 10.1002/jmv.27273] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Maigoro AY, An D, Lee S. Exploring the Link Between Vitamin D Deficiency and Cytokine Storms in COVID-19 Patients: An In Silico Analysis. J Med Food 2022;25:130-7. [PMID: 35148193 DOI: 10.1089/jmf.2021.K.0085] [Reference Citation Analysis]
13 Mslati H, Gentile F, Perez C, Cherkasov A. Comprehensive Consensus Analysis of SARS-CoV-2 Drug Repurposing Campaigns. J Chem Inf Model 2021;61:3771-88. [PMID: 34313439 DOI: 10.1021/acs.jcim.1c00384] [Reference Citation Analysis]
14 Cryer MJ, Farhan S, Kaufmann CC, Jäger B, Garg A, Krishnan P, Mehran R, Huber K. Prothrombotic Milieu, Thrombotic Events and Prophylactic Anticoagulation in Hospitalized COVID-19 Positive Patients: A Review. Clin Appl Thromb Hemost 2022;28:107602962210743. [DOI: 10.1177/10760296221074353] [Reference Citation Analysis]
15 Wang R. Etoricoxib may inhibit cytokine storm to treat COVID-19. Med Hypotheses 2021;150:110557. [PMID: 33730601 DOI: 10.1016/j.mehy.2021.110557] [Reference Citation Analysis]
16 Conti V, Corbi G, Sellitto C, Sabbatino F, Maci C, Bertini N, De Bellis E, Iuliano A, Davinelli S, Pagliano P, Filippelli A. Effect of Tocilizumab in Reducing the Mortality Rate in COVID-19 Patients: A Systematic Review with Meta-Analysis. J Pers Med 2021;11:628. [PMID: 34357095 DOI: 10.3390/jpm11070628] [Reference Citation Analysis]
17 Ashrafi F, Nematollahi P, Salmasi M, Hedayat A, Amra B. Association of lymphocyte subsets with mortality in severe COVID-19 pneumonia patients. J Clin Lab Anal 2021;35:e24046. [PMID: 34626490 DOI: 10.1002/jcla.24046] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
18 Ruggeri RM, Campennì A, Deandreis D, Siracusa M, Tozzoli R, Petranović Ovčariček P, Giovanella L. SARS-COV-2-related immune-inflammatory thyroid disorders: facts and perspectives. Expert Rev Clin Immunol 2021;17:737-59. [PMID: 34015983 DOI: 10.1080/1744666X.2021.1932467] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Stella GM, Piloni D, Accordino G, Grosso A, Albicini F, Gini E, Mancinelli S, Della Zoppa M, Marchelli APG, Bortolotto C, Corsico AG. COVID-19 epidemic in a Respiratory Diseases Unit: predictor ranking and mining. J Thorac Dis 2021;13:2569-74. [PMID: 34012603 DOI: 10.21037/jtd-20-2934] [Reference Citation Analysis]
20 Furqan MM, Verma BR, Cremer PC, Imazio M, Klein AL. Pericardial Diseases in COVID19: a Contemporary Review. Curr Cardiol Rep 2021;23:90. [PMID: 34081219 DOI: 10.1007/s11886-021-01519-x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
21 Rutledge AC, Choi YH, Karp I, Bhayana V, Stevic I. Biochemistry tests in hospitalized COVID-19 patients: Experience from a Canadian tertiary care centre. Clin Biochem 2021;95:41-8. [PMID: 34022172 DOI: 10.1016/j.clinbiochem.2021.05.008] [Reference Citation Analysis]
22 Coleman MJ, Zimmerly KM, Yang XO. Accumulation of CD28null Senescent T-Cells Is Associated with Poorer Outcomes in COVID19 Patients. Biomolecules 2021;11:1425. [PMID: 34680058 DOI: 10.3390/biom11101425] [Reference Citation Analysis]
23 Luo MH, Qian YQ, Huang DL, Luo JC, Su Y, Wang H, Yu SJ, Liu K, Tu GW, Luo Z. Tailoring glucocorticoids in patients with severe COVID-19: a narrative review. Ann Transl Med 2021;9:1261. [PMID: 34532398 DOI: 10.21037/atm-21-1783] [Reference Citation Analysis]
24 Oguz SH, Koca M, Yildiz BO. Aging versus youth: Endocrine aspects of vulnerability for COVID-19. Rev Endocr Metab Disord 2021. [PMID: 33860905 DOI: 10.1007/s11154-021-09656-y] [Reference Citation Analysis]
25 Rana P, Chauhan S, Mubayi A. Burden of cytokines storm on prognosis of SARS-CoV-2 infection through immune response: dynamic analysis and optimal control with immunomodulatory therapy. Eur Phys J Spec Top . [DOI: 10.1140/epjs/s11734-022-00435-7] [Reference Citation Analysis]
26 Ramli FF, Ali A, Syed Hashim SA, Kamisah Y, Ibrahim N. Reduction in Absolute Neutrophil Counts in Patient on Clozapine Infected with COVID-19. Int J Environ Res Public Health 2021;18:11289. [PMID: 34769806 DOI: 10.3390/ijerph182111289] [Reference Citation Analysis]
27 Samsami M, Fatemi A, Jalili Khoshnoud R, Kohansal K, Hussen BM, Soghala S, Taheri M, Ghafouri-Fard S. Abnormal Transcript Levels of Cytokines Among Iranian COVID-19 Patients. J Mol Neurosci 2021. [PMID: 34855144 DOI: 10.1007/s12031-021-01941-4] [Reference Citation Analysis]
28 Meskini M, Rezghi Rami M, Maroofi P, Ghosh S, Siadat SD, Sheikhpour M. An Overview on the Epidemiology and Immunology of COVID-19. J Infect Public Health 2021;14:1284-98. [PMID: 34420903 DOI: 10.1016/j.jiph.2021.07.021] [Reference Citation Analysis]
29 Zarrilli G, Angerilli V, Businello G, Sbaraglia M, Traverso G, Fortarezza F, Rizzo S, De Gaspari M, Basso C, Calabrese F, Dei Tos AP, Fassan M. The Immunopathological and Histological Landscape of COVID-19-Mediated Lung Injury. Int J Mol Sci 2021;22:974. [PMID: 33478107 DOI: 10.3390/ijms22020974] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
30 Fernández-Ruiz M, Aguado JM. Immunomodulatory Therapies for COVID-19 in Solid Organ Transplant Recipients. Curr Transplant Rep 2020;:1-11. [PMID: 33110739 DOI: 10.1007/s40472-020-00306-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
31 Kaur G, Yogeswaran S, Muthumalage T, Rahman I. Persistently Increased Systemic ACE2 Activity Is Associated With an Increased Inflammatory Response in Smokers With COVID-19. Front Physiol 2021;12:653045. [PMID: 34122129 DOI: 10.3389/fphys.2021.653045] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
32 Adamik B, Ambrożek-Latecka M, Dragan B, Jeznach A, Śmiechowicz J, Gożdzik W, Skirecki T. Inflammasome-related Markers upon ICU Admission do not Correlate with Outcome in Critically Ill COVID-19 Patients. Shock 2022;57:672-9. [PMID: 35583911 DOI: 10.1097/SHK.0000000000001923] [Reference Citation Analysis]
33 Abu-El-Rub E, Khasawneh RR, Almahasneh F, Altaany Z, Bataineh N, Zegallai H, Sekaran S. Mesenchymal stem cells and COVID-19: What they do and what they can do. World J Stem Cells 2021; 13(9): 1318-1337 [PMID: 34630865 DOI: 10.4252/wjsc.v13.i9.1318] [Reference Citation Analysis]
34 Kawakami R, Sakamoto A, Kawai K, Gianatti A, Pellegrini D, Nasr A, Kutys B, Guo L, Cornelissen A, Mori M, Sato Y, Pescetelli I, Brivio M, Romero M, Guagliumi G, Virmani R, Finn AV. Pathological Evidence for SARS-CoV-2 as a Cause of Myocarditis: JACC Review Topic of the Week. J Am Coll Cardiol 2021;77:314-25. [PMID: 33478655 DOI: 10.1016/j.jacc.2020.11.031] [Cited by in Crossref: 39] [Cited by in F6Publishing: 33] [Article Influence: 39.0] [Reference Citation Analysis]
35 Tripathy S, Singh N, Singh A, Kar SK. COVID-19 and Psychotic Symptoms: the View from Psychiatric Immunology. Curr Behav Neurosci Rep 2021;:1-7. [PMID: 34631364 DOI: 10.1007/s40473-021-00235-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Singh L, Bajaj S, Gadewar M, Verma N, Ansari MN, Saeedan AS, Kaithwas G, Singh M. Modulation of Host Immune Response Is an Alternative Strategy to Combat SARS-CoV-2 Pathogenesis. Front Immunol 2021;12:660632. [PMID: 34305892 DOI: 10.3389/fimmu.2021.660632] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
37 Darif D, Hammi I, Kihel A, El Idrissi Saik I, Guessous F, Akarid K. The pro-inflammatory cytokines in COVID-19 pathogenesis: What goes wrong?Microb Pathog. 2021;153:104799. [PMID: 33609650 DOI: 10.1016/j.micpath.2021.104799] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 11.0] [Reference Citation Analysis]
38 Azabou E, Bao G, Bounab R, Heming N, Annane D. Vagus Nerve Stimulation: A Potential Adjunct Therapy for COVID-19. Front Med (Lausanne) 2021;8:625836. [PMID: 34026778 DOI: 10.3389/fmed.2021.625836] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
39 Lauro R, Irrera N, Eid AH, Bitto A. Could Antigen Presenting Cells Represent a Protective Element during SARS-CoV-2 Infection in Children? Pathogens 2021;10:476. [PMID: 33920011 DOI: 10.3390/pathogens10040476] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
40 Quarleri J, Delpino MV. SARS-CoV-2 interacts with renin-angiotensin system: impact on the central nervous system in elderly patients. Geroscience 2022. [PMID: 35157210 DOI: 10.1007/s11357-022-00528-0] [Reference Citation Analysis]
41 Morris G, Bortolasci CC, Puri BK, Marx W, O'Neil A, Athan E, Walder K, Berk M, Olive L, Carvalho AF, Maes M. The cytokine storms of COVID-19, H1N1 influenza, CRS and MAS compared. Can one sized treatment fit all? Cytokine 2021;144:155593. [PMID: 34074585 DOI: 10.1016/j.cyto.2021.155593] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
42 Aliabadi F, Ajami M, Pazoki–toroudi H. Why does COVID‐19 pathology have several clinical forms? BioEssays 2020;42:2000198. [DOI: 10.1002/bies.202000198] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
43 Rodriguez Lima DR, Pinzón Rondón ÁM, Rubio Ramos C, Pinilla Rojas DI, Niño Orrego MJ, Díaz Quiroz MA, Molano-González N, Ceballos Quintero JE, Arroyo Santos AF, Ruiz Sternberg ÁM. Clinical characteristics and mortality associated with COVID-19 at high altitude: a cohort of 5161 patients in Bogotá, Colombia. Int J Emerg Med 2022;15:22. [PMID: 35597911 DOI: 10.1186/s12245-022-00426-4] [Reference Citation Analysis]
44 Arjmand B, Alavi-Moghadam S, Parhizkar Roudsari P, Rezaei-Tavirani M, Rahim F, Gilany K, Mohamadi-Jahani F, Adibi H, Larijani B. COVID-19 Pathology on Various Organs and Regenerative Medicine and Stem Cell-Based Interventions. Front Cell Dev Biol 2021;9:675310. [PMID: 34195193 DOI: 10.3389/fcell.2021.675310] [Reference Citation Analysis]
45 Padhi S, Sanjukta S, Chourasia R, Labala RK, Singh SP, Rai AK. A Multifunctional Peptide From Bacillus Fermented Soybean for Effective Inhibition of SARS-CoV-2 S1 Receptor Binding Domain and Modulation of Toll Like Receptor 4: A Molecular Docking Study. Front Mol Biosci 2021;8:636647. [PMID: 33869283 DOI: 10.3389/fmolb.2021.636647] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
46 Wray S, Arrowsmith S. The Physiological Mechanisms of the Sex-Based Difference in Outcomes of COVID19 Infection. Front Physiol 2021;12:627260. [PMID: 33633588 DOI: 10.3389/fphys.2021.627260] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
47 McGrowder DA, Miller F, Anderson Cross M, Anderson-Jackson L, Bryan S, Dilworth L. Abnormal Liver Biochemistry Tests and Acute Liver Injury in COVID-19 Patients: Current Evidence and Potential Pathogenesis. Diseases 2021;9:50. [PMID: 34287285 DOI: 10.3390/diseases9030050] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
48 Amaral JL, Oliveira JTA, Lopes FES, Freitas CDT, Freire VN, Abreu LV, Souza PFN. Quantum biochemistry, molecular docking, and dynamics simulation revealed synthetic peptides induced conformational changes affecting the topology of the catalytic site of SARS-CoV-2 main protease. J Biomol Struct Dyn 2021;:1-13. [PMID: 33949286 DOI: 10.1080/07391102.2021.1920464] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
49 Cui X, Chen W, Zhou H, Gong Y, Zhu B, Lv X, Guo H, Duan J, Zhou J, Marcon E, Ma H. Pulmonary Edema in COVID-19 Patients: Mechanisms and Treatment Potential. Front Pharmacol 2021;12:664349. [PMID: 34163357 DOI: 10.3389/fphar.2021.664349] [Reference Citation Analysis]
50 Kirkby C. A model of infection and immune response to low dose radiation. Int J Radiat Biol 2022;:1-14. [PMID: 34995150 DOI: 10.1080/09553002.2022.2020361] [Reference Citation Analysis]
51 Zeng X, Jiang X, Yang L, Pan Y, Li Y. COVID-19 and Cancer: Discovery of Difference in Clinical Immune Indexes. J Immunol Res 2021;2021:8669098. [PMID: 34712741 DOI: 10.1155/2021/8669098] [Reference Citation Analysis]
52 Heida R, Hinrichs WL, Frijlink HW. Inhaled vaccine delivery in the combat against respiratory viruses: a 2021 overview of recent developments and implications for COVID-19. Expert Rev Vaccines 2021;:1-18. [PMID: 33749491 DOI: 10.1080/14760584.2021.1903878] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
53 Elkhaled W, Ben Abid F, Akhtar N, Abukamar MR, Ibrahim WH. A 23-Year-Old Man with SARS-CoV-2 Infection Who Presented with Auditory Hallucinations and Imaging Findings of Cytotoxic Lesions of the Corpus Callosum (CLOCC). Am J Case Rep 2020;21:e928798. [PMID: 33315854 DOI: 10.12659/AJCR.928798] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
54 Mahler M, Meroni PL, Infantino M, Buhler KA, Fritzler MJ. Circulating Calprotectin as a Biomarker of COVID-19 Severity. Expert Rev Clin Immunol 2021;17:431-43. [PMID: 33750254 DOI: 10.1080/1744666X.2021.1905526] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
55 Thomas KE, Karamanis A, Dauchy E, Chapple AG, Loch MM. Assessing the effect of blood type on death and a novel scoring system to assess clinical course in patients with COVID-19. Am J Med Sci 2022:S0002-9629(21)00432-8. [PMID: 34986364 DOI: 10.1016/j.amjms.2021.12.006] [Reference Citation Analysis]
56 Kreiser T, Zaguri D, Sachdeva S, Zamostiano R, Mograbi J, Segal D, Bacharach E, Gazit E. Inhibition of Respiratory RNA Viruses by a Composition of Ionophoric Polyphenols with Metal Ions. Pharmaceuticals 2022;15:377. [DOI: 10.3390/ph15030377] [Reference Citation Analysis]
57 Hellman T, Uusalo P, Järvisalo MJ. Renal Replacement Techniques in Septic Shock. Int J Mol Sci 2021;22:10238. [PMID: 34638575 DOI: 10.3390/ijms221910238] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
58 Akinosoglou K, Delastic AL, Dimakopoulou V, Marangos M, Gogos C. Elements of Th1/Th2 response and disease severity in COVID-19 patients: A short report. J Med Virol 2022;94:404-6. [PMID: 34460125 DOI: 10.1002/jmv.27313] [Reference Citation Analysis]
59 Juttukonda LJ, Wachman EM, Boateng J, Jain M, Benarroch Y, Taglauer ES. Decidual immune response following COVID-19 during pregnancy varies by timing of maternal SARS-CoV-2 infection. Journal of Reproductive Immunology 2022;151:103501. [DOI: 10.1016/j.jri.2022.103501] [Reference Citation Analysis]
60 Aras Júnior R, Durães A, Roever L, Macedo C, Aras MG, Nascimento L, Improta-Caria AC, De Sousa RAL, Mansueto GN. The Impact of COVID-19 on the Cardiovascular System. Rev Assoc Med Bras (1992) 2021;67Suppl 1:163-7. [PMID: 34259776 DOI: 10.1590/1806-9282.67.Suppl1.20201063] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
61 Watson A, Öberg L, Angermann B, Spalluto CM, Hühn M, Burke H, Cellura D, Freeman A, Muthas D, Etal D, Belfield G, Karlsson F, Nordström K, Ostridge K, Staples KJ, Wilkinson T; MICA II Studygroup. Dysregulation of COVID-19 related gene expression in the COPD lung. Respir Res 2021;22:164. [PMID: 34051791 DOI: 10.1186/s12931-021-01755-3] [Reference Citation Analysis]
62 Chu CF, Sabath F, Fibi-Smetana S, Sun S, Öllinger R, Noeßner E, Chao YY, Rinke L, Winheim E, Rad R, Krug AB, Taher L, Zielinski CE. Convalescent COVID-19 Patients Without Comorbidities Display Similar Immunophenotypes Over Time Despite Divergent Disease Severities. Front Immunol 2021;12:601080. [PMID: 34867933 DOI: 10.3389/fimmu.2021.601080] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
63 Maraolo AE, Crispo A, Piezzo M, Di Gennaro P, Vitale MG, Mallardo D, Ametrano L, Celentano E, Cuomo A, Ascierto PA, Cascella M. The Use of Tocilizumab in Patients with COVID-19: A Systematic Review, Meta-Analysis and Trial Sequential Analysis of Randomized Controlled Studies. J Clin Med 2021;10:4935. [PMID: 34768455 DOI: 10.3390/jcm10214935] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
64 Rahman HS, Abdulateef DS, Hussen NH, Salih AF, Othman HH, Mahmood Abdulla T, Omer SHS, Mohammed TH, Mohammed MO, Aziz MS, Abdullah R. Recent Advancements on COVID-19: A Comprehensive Review. Int J Gen Med 2021;14:10351-72. [PMID: 34992449 DOI: 10.2147/IJGM.S339475] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
65 Dabbish AM, Yonis N, Salama M, Essa MM, Qoronfleh MW. Inflammatory pathways and potential therapies for COVID-19: A mini review. Eur J Inflamm 2021;19:205873922110029. [DOI: 10.1177/20587392211002986] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
66 Pascoal LB, Rodrigues PB, Genaro LM, Gomes ABDSP, Toledo-Teixeira DA, Parise PL, Bispo-Dos-Santos K, Simeoni CL, Guimarães PV, Buscaratti LI, Elston JGA, Marques-Souza H, Martins-de-Souza D, Ayrizono MLS, Velloso LA, Proenca-Modena JL, Moraes-Vieira PMM, Mori MAS, Farias AS, Vinolo MAR, Leal RF. Microbiota-derived short-chain fatty acids do not interfere with SARS-CoV-2 infection of human colonic samples. Gut Microbes 2021;13:1-9. [PMID: 33550892 DOI: 10.1080/19490976.2021.1874740] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
67 Mohiuddin M, Kasahara K. The emerging role of cellular senescence in complications of COVID-19. Cancer Treat Res Commun 2021;28:100399. [PMID: 34023769 DOI: 10.1016/j.ctarc.2021.100399] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
68 Rastogi A, Dogra H, Jude EB. COVID-19 and peripheral arterial complications in people with diabetes and hypertension: A systematic review. Diabetes Metab Syndr 2021;15:102204. [PMID: 34303918 DOI: 10.1016/j.dsx.2021.102204] [Reference Citation Analysis]
69 Valeri A, Chiricosta L, Calcaterra V, Biasin M, Cappelletti G, Carelli S, Zuccotti GV, Bramanti P, Pelizzo G, Mazzon E, Gugliandolo A. Transcriptomic Analysis of HCN-2 Cells Suggests Connection among Oxidative Stress, Senescence, and Neuron Death after SARS-CoV-2 Infection. Cells 2021;10:2189. [PMID: 34571838 DOI: 10.3390/cells10092189] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
70 Thangavel N, Al Bratty M, Al Hazmi HA, Najmi A, Ali Alaqi RO. Molecular Docking and Molecular Dynamics Aided Virtual Search of OliveNet™ Directory for Secoiridoids to Combat SARS-CoV-2 Infection and Associated Hyperinflammatory Responses. Front Mol Biosci 2020;7:627767. [PMID: 33490110 DOI: 10.3389/fmolb.2020.627767] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
71 Theoharides TC, Cholevas C, Polyzoidis K, Politis A. Long-COVID syndrome-associated brain fog and chemofog: Luteolin to the rescue. Biofactors 2021;47:232-41. [PMID: 33847020 DOI: 10.1002/biof.1726] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
72 Olajide OA, Iwuanyanwu VU, Lepiarz-Raba I, Al-Hindawi AA, Aderogba MA, Sharp HL, Nash RJ. Garcinia kola and garcinoic acid suppress SARS-CoV-2 spike glycoprotein S1-induced hyper-inflammation in human PBMCs through inhibition of NF-κB activation. Phytother Res 2021. [PMID: 34697842 DOI: 10.1002/ptr.7315] [Reference Citation Analysis]
73 Panda B, Sharma Y, Gupta S, Mohanty S. Mesenchymal Stem Cell-Derived Exosomes as an Emerging Paradigm for Regenerative Therapy and Nano-Medicine: A Comprehensive Review. Life (Basel) 2021;11:784. [PMID: 34440528 DOI: 10.3390/life11080784] [Reference Citation Analysis]
74 Nair AP, Soliman A, Al Masalamani MA, De Sanctis V, Nashwan AJ, Sasi S, Ali EA, Hassan OA, Iqbal FM, Yassin MA. Clinical Outcome of Eosinophilia in Patients with COVID-19: A Controlled Study. Acta Biomed 2020;91:e2020165. [PMID: 33525219 DOI: 10.23750/abm.v91i4.10564] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
75 Meijer RI, Hoekstra T, van den Oever NCG, Simsek S, van den Bergh JP, Douma RA, Reidinga AC, Moeniralam HS, Dormans T, Smits MM; Amsterdam UMC COVID-19 biobank study group. Treatment with a DPP-4 inhibitor at time of hospital admission for COVID-19 is not associated with improved clinical outcomes: data from the COVID-PREDICT cohort study in The Netherlands. J Diabetes Metab Disord 2021;:1-6. [PMID: 34222054 DOI: 10.1007/s40200-021-00833-z] [Reference Citation Analysis]
76 Díaz F, Cores C, Atenas O, Rodríguez N, Bustos R, Cruces P. Rationale of Therapeutic Plasma Exchange as Rescue Immunomodulatory Treatment for MIS-C With Multiorgan Failure. Pediatr Infect Dis J 2021;40:e259-62. [PMID: 34097663 DOI: 10.1097/INF.0000000000003169] [Reference Citation Analysis]
77 Biswas B, Chattopadhyay S, Hazra S, Hansda AK, Goswami R. COVID-19 pandemic: the delta variant, T-cell responses, and the efficacy of developing vaccines. Inflamm Res 2022. [PMID: 35292834 DOI: 10.1007/s00011-022-01555-5] [Reference Citation Analysis]
78 Islam H, Chamberlain TC, Mui AL, Little JP. Elevated Interleukin-10 Levels in COVID-19: Potentiation of Pro-Inflammatory Responses or Impaired Anti-Inflammatory Action? Front Immunol 2021;12:677008. [PMID: 34234779 DOI: 10.3389/fimmu.2021.677008] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
79 Abedini A, Mahdavi A, Mirza Alizadeh A, Hejazi E, Hosseini H. A Review on Dietary Additive, Food Supplement and Exercise Effects on the Prevention of Covid-19. Nutr Food Sci Res 2022;9:1-14. [DOI: 10.52547/nfsr.9.1.1] [Reference Citation Analysis]
80 Niedźwiedzka-Rystwej P, Grywalska E, Hrynkiewicz R, Bębnowska D, Wołącewicz M, Majchrzak A, Parczewski M. Interplay between Neutrophils, NETs and T-Cells in SARS-CoV-2 Infection-A Missing Piece of the Puzzle in the COVID-19 Pathogenesis? Cells 2021;10:1817. [PMID: 34359987 DOI: 10.3390/cells10071817] [Reference Citation Analysis]
81 Gupta A, Chun HJ. Interleukin-1- Receptor Kinase 4 Inhibition: Achieving Immunomodulatory Synergy to Mitigate the Impact of COVID-19. Front Immunol 2021;12:693085. [PMID: 34248990 DOI: 10.3389/fimmu.2021.693085] [Reference Citation Analysis]
82 Williams TL, Rada B, Tandon E, Gestal MC. "NETs and EETs, a Whole Web of Mess". Microorganisms 2020;8:E1925. [PMID: 33291570 DOI: 10.3390/microorganisms8121925] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
83 Ebrahimi M, Rad MTS, Zebardast A, Ayyasi M, Goodarzi G, Tehrani SS. The critical role of mesenchymal stromal/stem cell therapy in COVID-19 patients: An updated review. Cell Biochem Funct 2021. [PMID: 34545605 DOI: 10.1002/cbf.3670] [Reference Citation Analysis]
84 Sur S, Khatun M, Steele R, Isbell TS, Ray R, Ray RB. Exosomes from COVID-19 Patients Carry Tenascin-C and Fibrinogen-β in Triggering Inflammatory Signals in Cells of Distant Organ. Int J Mol Sci 2021;22:3184. [PMID: 33804769 DOI: 10.3390/ijms22063184] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
85 Ataba E, Dorkenoo AM, Nguepou CT, Bakai T, Tchadjobo T, Kadzahlo KD, Yakpa K, Atcha-Oubou T. Potential Emergence of Plasmodium Resistance to Artemisinin Induced by the Use of Artemisia annua for Malaria and COVID-19 Prevention in Sub-African Region. Acta Parasitol 2021. [PMID: 34797496 DOI: 10.1007/s11686-021-00489-y] [Reference Citation Analysis]
86 Elrobaa IH, New KJ. COVID-19: Pulmonary and Extra Pulmonary Manifestations. Front Public Health 2021;9:711616. [PMID: 34650947 DOI: 10.3389/fpubh.2021.711616] [Reference Citation Analysis]
87 Zoulikha M, Huang F, Wu Z, He W. COVID-19 inflammation and implications in drug delivery. J Control Release 2022;346:260-74. [PMID: 35469984 DOI: 10.1016/j.jconrel.2022.04.027] [Reference Citation Analysis]
88 Capaccione KM, Mcgroder C, Garcia CK, Fedyna S, Saqi A, Salvatore MM. COVID-19-induced pulmonary sarcoid: A case report and review of the literature. Clinical Imaging 2022;83:152-8. [DOI: 10.1016/j.clinimag.2021.12.021] [Reference Citation Analysis]
89 Witkowski JM. Immune system aging and the aging-related diseases in the COVIID-19 era. Immunology Letters 2022. [DOI: 10.1016/j.imlet.2022.01.005] [Reference Citation Analysis]
90 Malavige GN, Jeewandara C, Ogg GS. Dysfunctional Innate Immune Responses and Severe Dengue. Front Cell Infect Microbiol 2020;10:590004. [PMID: 33194836 DOI: 10.3389/fcimb.2020.590004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
91 Marcinkiewicz J, Witkowski JM, Olszanecki R. The dual role of the immune system in the course of COVID-19. The fatal impact of the aging immune system. Cent Eur J Immunol 2021;46:1-9. [PMID: 33897278 DOI: 10.5114/ceji.2021.105240] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
92 Fan Y, Wang Y, Yu S, Chang J, Yan Y, Wang Y, Bian Y. Natural products provide a new perspective for anti-complement treatment of severe COVID-19: a review. Chin Med 2021;16:67. [PMID: 34321065 DOI: 10.1186/s13020-021-00478-3] [Reference Citation Analysis]
93 Tang KT, Hsu BC, Chen DY. Autoimmune and Rheumatic Manifestations Associated With COVID-19 in Adults: An Updated Systematic Review. Front Immunol 2021;12:645013. [PMID: 33777042 DOI: 10.3389/fimmu.2021.645013] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
94 Narala VR, Thimmana LV, Panati K, Kolliputi N. Nitrated fatty acid, 10-nitrooleate protects against hyperoxia-induced acute lung injury in mice. Int Immunopharmacol 2022;109:108838. [PMID: 35561478 DOI: 10.1016/j.intimp.2022.108838] [Reference Citation Analysis]
95 Yiangou L, Davis RP, Mummery CL. Using Cardiovascular Cells from Human Pluripotent Stem Cells for COVID-19 Research: Why the Heart Fails. Stem Cell Reports. 2021;16:385-397. [PMID: 33306986 DOI: 10.1016/j.stemcr.2020.11.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
96 Chatterjee S, Mishra S, Chowdhury KD, Ghosh CK, Saha KD. Various theranostics and immunization strategies based on nanotechnology against Covid-19 pandemic: An interdisciplinary view. Life Sci 2021;278:119580. [PMID: 33991549 DOI: 10.1016/j.lfs.2021.119580] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
97 Verma HK, Bhaskar L. SARS-CoV-2 infection in people with pre-existing liver disease: Further research is warranted. World J Gastroenterol 2021; 27(45): 7855-7858 [PMID: 34963747 DOI: 10.3748/wjg.v27.i45.7855] [Reference Citation Analysis]
98 Nassar M, Nso N, Gonzalez C, Lakhdar S, Alshamam M, Elshafey M, Abdalazeem Y, Nyein A, Punzalan B, Durrance RJ, Alfishawy M, Bakshi S, Rizzo V. COVID-19 vaccine-induced myocarditis: Case report with literature review. Diabetes Metab Syndr 2021;15:102205. [PMID: 34293552 DOI: 10.1016/j.dsx.2021.102205] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
99 Girón-Pérez DA, Benitez-Trinidad AB, Ruiz-Manzano RA, Toledo-Ibarra GA, Ventura-Ramón GH, Covantes-Rosales CE, Ojeda-Durán AJ, Díaz-Reséndiz KJG, Mercado-Salgado U, Girón-Pérez MI. Correlation of hematological parameters and cycle threshold in ambulatory patients with SARS-CoV-2 infection. Int J Lab Hematol 2021;43:873-80. [PMID: 34075710 DOI: 10.1111/ijlh.13606] [Reference Citation Analysis]
100 Kilic G, Bulut O, Jaeger M, Ter Horst R, Koeken VACM, Moorlag SJCFM, Mourits VP, de Bree C, Domínguez-Andrés J, Joosten LAB, Netea MG. The Immunological Factors Predisposing to Severe Covid-19 Are Already Present in Healthy Elderly and Men. Front Immunol 2021;12:720090. [PMID: 34434199 DOI: 10.3389/fimmu.2021.720090] [Reference Citation Analysis]
101 Ceriello A, Prattichizzo F. Pharmacological management of COVID-19 in type 2 diabetes. J Diabetes Complications 2021;35:107927. [PMID: 33896714 DOI: 10.1016/j.jdiacomp.2021.107927] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
102 Kwak SG, Choo YJ, Chang MC. The effectiveness of high-dose intravenous vitamin C for patients with coronavirus disease 2019: A systematic review and meta-analysis. Complement Ther Med 2021;64:102797. [PMID: 34953366 DOI: 10.1016/j.ctim.2021.102797] [Reference Citation Analysis]
103 Guloyan V, Oganesian B, Baghdasaryan N, Yeh C, Singh M, Guilford F, Ting YS, Venketaraman V. Glutathione Supplementation as an Adjunctive Therapy in COVID-19. Antioxidants (Basel) 2020;9:E914. [PMID: 32992775 DOI: 10.3390/antiox9100914] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
104 Halim C, Mirza AF, Sari MI. The Association between TNF-α, IL-6, and Vitamin D Levels and COVID-19 Severity and Mortality: A Systematic Review and Meta-Analysis. Pathogens 2022;11:195. [DOI: 10.3390/pathogens11020195] [Reference Citation Analysis]
105 Mittal A, Dua A, Gupta S, Injeti E. A research update: Significance of cytokine storm and diaphragm in COVID-19. Curr Res Pharmacol Drug Discov 2021;2:100031. [PMID: 34870147 DOI: 10.1016/j.crphar.2021.100031] [Reference Citation Analysis]
106 Milenkovic M, Hadzibegovic A, Kovac M, Jovanovic B, Stanisavljevic J, Djikic M, Sijan D, Ladjevic N, Palibrk I, Djukanovic M, Velickovic J, Ratkovic S, Brajkovic M, Popadic V, Klasnja S, Toskovic B, Zdravkovic D, Crnokrak B, Markovic O, Bjekic-Macut J, Aleksic A, Petricevic S, Memon L, Milojevic A, Zdravkovic M. D-dimer, CRP, PCT, and IL-6 Levels at Admission to ICU Can Predict In-Hospital Mortality in Patients with COVID-19 Pneumonia. Oxid Med Cell Longev 2022;2022:8997709. [PMID: 35237386 DOI: 10.1155/2022/8997709] [Reference Citation Analysis]
107 Hertanto DM, Sutanto H, Wiratama BS, Wungu CDK. Modulating the host immune response to fight against COVID-19: Where are we in 2021? Virulence 2021;12:1732-6. [PMID: 34224330 DOI: 10.1080/21505594.2021.1943275] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
108 Shetty L, Nahar S, Domah T, Raj AT. COVID-19 patients could be at high risk for dry socket. Med Hypotheses 2021;146:110462. [PMID: 33352433 DOI: 10.1016/j.mehy.2020.110462] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
109 Kumar Yadalam P, Madapusi Balaji T, Varadarajan S, Alzahrani KJ, Al-ghamdi MS, Ali Baeshen H, Farhan A Alfarhan M, Khurshid Z, Bhandi S, Jagannathan R, Patil VR, Thirumal Raj A, Ratnayake J, Patil S. Assessing the therapeutic potential of angomelatine, ramelteon, and melatonin against SARS-Cov-2. Saudi Journal of Biological Sciences 2022. [DOI: 10.1016/j.sjbs.2022.01.049] [Reference Citation Analysis]
110 Mikuła-Pietrasik J, Książek K. Aging correlates with lower threshold cycle values for RdRP/RdRP+S genes during molecular detection of SARS-CoV-2. Exp Gerontol 2021;150:111361. [PMID: 33878423 DOI: 10.1016/j.exger.2021.111361] [Reference Citation Analysis]
111 Liu TFD, Philippou E, Kolokotroni O, Siakallis G, Rahima K, Constantinou C. Gut and airway microbiota and their role in COVID-19 infection and pathogenesis: a scoping review. Infection 2021. [PMID: 34671922 DOI: 10.1007/s15010-021-01715-5] [Reference Citation Analysis]
112 Stasiłowicz A, Tomala A, Podolak I, Cielecka-Piontek J. Cannabis sativa L. as a Natural Drug Meeting the Criteria of a Multitarget Approach to Treatment. Int J Mol Sci 2021;22:E778. [PMID: 33466734 DOI: 10.3390/ijms22020778] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
113 [DOI: 10.1101/2020.10.26.355107] [Cited by in Crossref: 17] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
114 Paul S, Bravo Vázquez LA, Reyes-Pérez PR, Estrada-Meza C, Aponte Alburquerque RA, Pathak S, Banerjee A, Bandyopadhyay A, Chakraborty S, Srivastava A. The role of microRNAs in solving COVID-19 puzzle from infection to therapeutics: A mini-review. Virus Res 2021;308:198631. [PMID: 34788642 DOI: 10.1016/j.virusres.2021.198631] [Reference Citation Analysis]
115 Battina HL, Alentado VJ, Srour EF, Moliterno AR, Kacena MA. Interaction of the inflammatory response and megakaryocytes in COVID-19 infection. Exp Hematol 2021:S0301-472X(21)00328-3. [PMID: 34563606 DOI: 10.1016/j.exphem.2021.09.005] [Reference Citation Analysis]
116 Kanimozhi G, Pradhapsingh B, Singh Pawar C, Khan HA, Alrokayan SH, Prasad NR. SARS-CoV-2: Pathogenesis, Molecular Targets and Experimental Models. Front Pharmacol 2021;12:638334. [PMID: 33967772 DOI: 10.3389/fphar.2021.638334] [Reference Citation Analysis]
117 Singh H, Chauhan P, Singh J, Saurabh, Gautam CS, Kakkar AK. Concomitant use of dexamethasone and tetracyclines: a potential therapeutic option for the management of severe COVID-19 infection? Expert Rev Clin Pharmacol 2021;14:315-22. [PMID: 33586566 DOI: 10.1080/17512433.2021.1888714] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
118 Ferreira C, Viana SD, Reis F. Is Gut Microbiota Dysbiosis a Predictor of Increased Susceptibility to Poor Outcome of COVID-19 Patients? An Update. Microorganisms 2020;9:E53. [PMID: 33379162 DOI: 10.3390/microorganisms9010053] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
119 Lo Sasso B, Gambino CM, Scichilone N, Giglio RV, Bivona G, Scazzone C, Muratore R, Milano S, Barbagallo M, Agnello L, Ciaccio M. Clinical Utility of Midregional Proadrenomedullin in Patients with COVID-19. Lab Med 2021:lmab032. [PMID: 33928380 DOI: 10.1093/labmed/lmab032] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
120 Achan J, Serwanga A, Wanzira H, Kyagulanyi T, Nuwa A, Magumba G, Kusasira S, Sewanyana I, Tetteh K, Drakeley C, Nakwagala F, Aanyu H, Opigo J, Hamade P, Marasciulo M, Baterana B, Tibenderana JK. Current malaria infection, previous malaria exposure, and clinical profiles and outcomes of COVID-19 in a setting of high malaria transmission: an exploratory cohort study in Uganda. Lancet Microbe 2021. [PMID: 34723228 DOI: 10.1016/S2666-5247(21)00240-8] [Reference Citation Analysis]
121 Ponthieux F, Dauby N, Maillart E, Fils JF, Smet J, Claus M, Besse-Hammer T, Bels D, Corazza F, Nagant C. Tocilizumab-Induced Unexpected Increase of Several Inflammatory Cytokines in Critically Ill COVID-19 Patients: The Anti-Inflammatory Side of IL-6. Viral Immunol 2022. [PMID: 35085462 DOI: 10.1089/vim.2021.0111] [Reference Citation Analysis]
122 Chen W, Tian Y, Li Z, Zhu J, Wei T, Lei J. Potential Interaction Between SARS-CoV-2 and Thyroid: A Review. Endocrinology 2021;162:bqab004. [PMID: 33543236 DOI: 10.1210/endocr/bqab004] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 10.0] [Reference Citation Analysis]
123 Qureshi AI, Baskett WI, Huang W, Shyu D, Myers D, Lobanova I, Ishfaq MF, Naqvi SH, French BR, Siddiq F, Gomez CR, Shyu CR. Subarachnoid Hemorrhage and COVID-19: An Analysis of 282,718 Patients. World Neurosurg 2021;151:e615-20. [PMID: 33940263 DOI: 10.1016/j.wneu.2021.04.089] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
124 Alshammary AF, Alsughayyir JM, Alharbi KK, Al-sulaiman AM, Alshammary HF, Alshammary HF. T-Cell Subsets and Interleukin-10 Levels Are Predictors of Severity and Mortality in COVID-19: A Systematic Review and Meta-Analysis. Front Med 2022;9:852749. [DOI: 10.3389/fmed.2022.852749] [Reference Citation Analysis]
125 Zhang Z, Cui F, Cao C, Wang Q, Zou Q. Single-cell RNA analysis reveals the potential risk of organ-specific cell types vulnerable to SARS-CoV-2 infections. Comput Biol Med 2021;140:105092. [PMID: 34864302 DOI: 10.1016/j.compbiomed.2021.105092] [Reference Citation Analysis]
126 Jha NK, Sharma C, Hashiesh HM, Arunachalam S, Meeran MN, Javed H, Patil CR, Goyal SN, Ojha S. β-Caryophyllene, A Natural Dietary CB2 Receptor Selective Cannabinoid can be a Candidate to Target the Trinity of Infection, Immunity, and Inflammation in COVID-19. Front Pharmacol 2021;12:590201. [PMID: 34054510 DOI: 10.3389/fphar.2021.590201] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
127 Huntington KE, Louie AD, Lee CG, Elias JA, Ross EA, El-Deiry WS. Cytokine ranking via mutual information algorithm correlates cytokine profiles with presenting disease severity in patients with COVID-19. medRxiv 2020:2020. [PMID: 33269361 DOI: 10.1101/2020.11.24.20235721] [Reference Citation Analysis]
128 Navya VB, Hosur MV. A computational study on hydroxychloroquine binding to target proteins related to SARS-COV-2 infection. Inform Med Unlocked 2021;26:100714. [PMID: 34458558 DOI: 10.1016/j.imu.2021.100714] [Reference Citation Analysis]
129 Williams A, Branscome H, Khatkar P, Mensah GA, Al Sharif S, Pinto DO, DeMarino C, Kashanchi F. A comprehensive review of COVID-19 biology, diagnostics, therapeutics, and disease impacting the central nervous system. J Neurovirol 2021;27:667-90. [PMID: 34581996 DOI: 10.1007/s13365-021-00998-6] [Reference Citation Analysis]
130 Brien ME, Bouron-Dal Soglio D, Dal Soglio S, Couture C, Boucoiran I, Nasr Y, Widdows K, Sharps MC, El Demellawy D, Ep Heazell A, Menzies D, Girard S. Pandemic stress and SARS-CoV-2 infection are associated with pathological changes at the maternal-fetal interface. Placenta 2021;115:37-44. [PMID: 34537470 DOI: 10.1016/j.placenta.2021.09.007] [Reference Citation Analysis]
131 Sun W, Zhang Y, Wu C, Wang S, Xie Y, Zhang D, Yuan H, Zhang Y, Cui L, Li M, Zhang Y, Li Y, Wang J, Yang Y, Lv Q, Zhang L, Haines P, Wu WC, Xie M. Early vs. Late Onset Cardiac Injury and Mortality in Hospitalized COVID-19 Patients in Wuhan. Front Cardiovasc Med 2021;8:645587. [PMID: 34124189 DOI: 10.3389/fcvm.2021.645587] [Reference Citation Analysis]
132 Saygili E, Yildiz-Ozturk E, Green MJ, Ghaemmaghami AM, Yesil-Celiktas O. Human lung-on-chips: Advanced systems for respiratory virus models and assessment of immune response. Biomicrofluidics 2021;15:021501. [PMID: 33791050 DOI: 10.1063/5.0038924] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
133 Theoharides TC. Could SARS-CoV-2 Spike Protein Be Responsible for Long-COVID Syndrome? Mol Neurobiol 2022. [PMID: 35028901 DOI: 10.1007/s12035-021-02696-0] [Reference Citation Analysis]
134 Ahmadi A, Moradi S. In silico analysis suggests the RNAi-enhancing antibiotic enoxacin as a potential inhibitor of SARS-CoV-2 infection. Sci Rep 2021;11:10271. [PMID: 33986351 DOI: 10.1038/s41598-021-89605-6] [Reference Citation Analysis]
135 Sukkar SG, Cogorno L, Pisciotta L, Pasta A, Vena A, Gradaschi R, Dentone C, Guiddo E, Martino E, Beltramini S, Donini LM, Carmisciano L, Sormani MP, Bassetti M; GECOVID Study Group. Clinical efficacy of eucaloric ketogenic nutrition in the COVID-19 cytokine storm: A retrospective analysis of mortality and intensive care unit admission. Nutrition 2021;89:111236. [PMID: 33895559 DOI: 10.1016/j.nut.2021.111236] [Reference Citation Analysis]
136 Sharma HN, Latimore COD, Matthews QL. Biology and Pathogenesis of SARS-CoV-2: Understandings for Therapeutic Developments against COVID-19. Pathogens 2021;10:1218. [PMID: 34578250 DOI: 10.3390/pathogens10091218] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
137 Satsangi S, Gupta N, Kodan P. Current and New Drugs for COVID-19 Treatment and Its Effects on the Liver. J Clin Transl Hepatol 2021;9:436-46. [PMID: 34221930 DOI: 10.14218/JCTH.2020.00174] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
138 Gong Y, Qin S, Dai L, Tian Z. The glycosylation in SARS-CoV-2 and its receptor ACE2. Signal Transduct Target Ther 2021;6:396. [PMID: 34782609 DOI: 10.1038/s41392-021-00809-8] [Reference Citation Analysis]
139 Afroja S, Sacchetti A. COVID-19 disease and the hyper-inflammatory response: Are we accusing the wrong suspect? Am J Emerg Med 2021;49:431. [PMID: 33722434 DOI: 10.1016/j.ajem.2021.02.063] [Reference Citation Analysis]
140 Tascioglu D, Akkaya E, Genc S. The understanding of the immunopathology in COVID-19 infection. Scand J Clin Lab Invest 2021;81:255-63. [PMID: 34032527 DOI: 10.1080/00365513.2021.1892817] [Reference Citation Analysis]
141 Kumar S, Shanker OR, Kumari N, Tripathi M, Chandra PS, Dixit AB, Banerjee J. Neuromodulatory effects of SARS-CoV2 infection: Possible therapeutic targets. Expert Opin Ther Targets 2021;25:509-19. [PMID: 34232801 DOI: 10.1080/14728222.2021.1953475] [Reference Citation Analysis]
142 Dos Santos WG. Impact of virus genetic variability and host immunity for the success of COVID-19 vaccines. Biomed Pharmacother 2021;136:111272. [PMID: 33486212 DOI: 10.1016/j.biopha.2021.111272] [Cited by in Crossref: 25] [Cited by in F6Publishing: 15] [Article Influence: 25.0] [Reference Citation Analysis]
143 Mohanta TK, Sharma N, Arina P, Defilippi P. Molecular Insights into the MAPK Cascade during Viral Infection: Potential Crosstalk between HCQ and HCQ Analogues. Biomed Res Int 2020;2020:8827752. [PMID: 33426074 DOI: 10.1155/2020/8827752] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
144 Sood A, Raghavan S, Batra P, Sharma K, Talwar A. Rise and exacerbation of oral lichen planus in the background of SARS-CoV-2 infection. Med Hypotheses 2021;156:110681. [PMID: 34601231 DOI: 10.1016/j.mehy.2021.110681] [Reference Citation Analysis]
145 Gröber U, Holick MF. The coronavirus disease (COVID-19) - A supportive approach with selected micronutrients. Int J Vitam Nutr Res 2021;:1-22. [PMID: 33487035 DOI: 10.1024/0300-9831/a000693] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
146 Chen PK, Chen DY. An Update on the Pathogenic Role of Macrophages in Adult-Onset Still's Disease and Its Implication in Clinical Manifestations and Novel Therapeutics. J Immunol Res 2021;2021:8998358. [PMID: 34239943 DOI: 10.1155/2021/8998358] [Reference Citation Analysis]
147 Omer D, Pleniceanu O, Gnatek Y, Namestnikov M, Cohen-Zontag O, Goldberg S, Friedman YE, Friedman N, Mandelboim M, Vitner EB, Achdout H, Avraham R, Zahavy E, Israely T, Mayan H, Dekel B. Human Kidney Spheroids and Monolayers Provide Insights into SARS-CoV-2 Renal Interactions. J Am Soc Nephrol 2021;32:2242-54. [PMID: 34112705 DOI: 10.1681/ASN.2020111546] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
148 Blum VF, Cimerman S, Hunter JR, Tierno P, Lacerda A, Soeiro A, Cardoso F, Bellei NC, Maricato J, Mantovani N, Vassao M, Dias D, Galinskas J, Janini LMR, Santos-Oliveira JR, Da-Cruz AM, Diaz RS. Nitazoxanide superiority to placebo to treat moderate COVID-19 - A Pilot prove of concept randomized double-blind clinical trial. EClinicalMedicine 2021;37:100981. [PMID: 34222847 DOI: 10.1016/j.eclinm.2021.100981] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
149 Umar AK, Zothantluanga JH, Aswin K, Maulana S, Sulaiman Zubair M, Lalhlenmawia H, Rudrapal M, Chetia D. Antiviral phytocompounds “ellagic acid” and “(+)-sesamin” of Bridelia retusa identified as potential inhibitors of SARS-CoV-2 3CL pro using extensive molecular docking, molecular dynamics simulation studies, binding free energy calculations, and bioactivity prediction. Struct Chem. [DOI: 10.1007/s11224-022-01959-3] [Reference Citation Analysis]
150 Acosta-Ampudia Y, Monsalve DM, Rojas M, Rodríguez Y, Gallo JE, Salazar-Uribe JC, Santander MJ, Cala MP, Zapata W, Zapata MI, Manrique R, Pardo-Oviedo JM, Camacho B, Ramírez-Santana C, Anaya JM; CP-COVID-19 group. COVID-19 convalescent plasma composition and immunological effects in severe patients. J Autoimmun 2021;118:102598. [PMID: 33524876 DOI: 10.1016/j.jaut.2021.102598] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 14.0] [Reference Citation Analysis]
151 Lorkiewicz P, Waszkiewicz N. Biomarkers of Post-COVID Depression. J Clin Med 2021;10:4142. [PMID: 34575258 DOI: 10.3390/jcm10184142] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
152 Hellou E, Mohsin J, Elemy A, Hakim F, Mustafa-Hellou M, Hamoud S. Effect of ArtemiC in patients with COVID-19: A Phase II prospective study. J Cell Mol Med 2022. [PMID: 35587574 DOI: 10.1111/jcmm.17337] [Reference Citation Analysis]
153 Nagoor Meeran MF, Javed H, Sharma C, Goyal SN, Kumar S, Jha NK, Ojha S. Can Echinacea be a potential candidate to target immunity, inflammation, and infection - The trinity of coronavirus disease 2019. Heliyon 2021;7:e05990. [PMID: 33585706 DOI: 10.1016/j.heliyon.2021.e05990] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
154 Dhawan M, Priyanka, Choudhary OP. Immunomodulatory and therapeutic implications of vitamin D in the management of COVID-19. Human Vaccines & Immunotherapeutics. [DOI: 10.1080/21645515.2022.2025734] [Reference Citation Analysis]
155 Kim NE, Kim DK, Song YJ. SARS-CoV-2 Nonstructural Proteins 1 and 13 Suppress Caspase-1 and the NLRP3 Inflammasome Activation. Microorganisms 2021;9:494. [PMID: 33652815 DOI: 10.3390/microorganisms9030494] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
156 Tang G, Huang M, Luo Y, Liu W, Lin Q, Mao L, Wu S, Xiong Z, Hou H, Sun Z, Wang F. The Dynamic Immunological Parameter Landscape in Coronavirus Disease 2019 Patients With Different Outcomes. Front Immunol 2021;12:697622. [PMID: 34777333 DOI: 10.3389/fimmu.2021.697622] [Reference Citation Analysis]
157 Devaux CA, Camoin-Jau L, Mege JL, Raoult D. Can hydroxychloroquine be protective against COVID-19-associated thrombotic events ? J Microbiol Immunol Infect 2021;54:37-45. [PMID: 33500211 DOI: 10.1016/j.jmii.2020.12.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
158 Al-Eitan LN, Alahmad SZ. Pharmacogenomics of genetic polymorphism within the genes responsible for SARS-CoV-2 susceptibility and the drug-metabolising genes used in treatment. Rev Med Virol 2021;31:e2194. [PMID: 33205496 DOI: 10.1002/rmv.2194] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
159 Singh AK, Kasarpalkar N, Bhowmick S, Paradkar G, Talreja M, Shah K, Tiwari A, Palav H, Kaginkar S, Kulkarni R, Patil A, Kalsurkar V, Agrawal S, Shastri J, Dere R, Bharmal R, Mahale SD, Bhor VM, Patel V. Opposing roles for sMAdCAM and IL‐15 in COVID‐19 associated cellular immune pathology. J Leukocyte Bio. [DOI: 10.1002/jlb.3covbcr0621-300r] [Reference Citation Analysis]
160 Garg SS, Sharma A, Gupta J. Immunomodulation and immunotherapeutics of COVID-19. Clin Immunol 2021;231:108842. [PMID: 34461289 DOI: 10.1016/j.clim.2021.108842] [Reference Citation Analysis]
161 Ginsburg I, Fibach E. Polycations and polyanions in SARS-CoV-2 infection. Med Hypotheses 2021;146:110470. [PMID: 33412501 DOI: 10.1016/j.mehy.2020.110470] [Reference Citation Analysis]
162 Roberts J, Pritchard AL, Treweeke AT, Rossi AG, Brace N, Cahill P, MacRury SM, Wei J, Megson IL. Why Is COVID-19 More Severe in Patients With Diabetes? The Role of Angiotensin-Converting Enzyme 2, Endothelial Dysfunction and the Immunoinflammatory System. Front Cardiovasc Med 2020;7:629933. [PMID: 33614744 DOI: 10.3389/fcvm.2020.629933] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
163 Rao Y, Wang TY, Qin C, Espinosa B, Liu Q, Ekanayake A, Zhao J, Savas AC, Zhang S, Zarinfar M, Liu Y, Zhu W, Graham NA, Jiang T, Zhang C, Feng P. Targeting CTP Synthetase 1 to Restore Interferon Induction and Impede Nucleotide Synthesis in SARS-CoV-2 Infection. bioRxiv 2021:2021. [PMID: 33564769 DOI: 10.1101/2021.02.05.429959] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
164 Urso L, Distefano MG, Cambula G, Colomba AI, Nuzzo D, Picone P, Giacomazza D, Sicurella L. The case of encephalitis in a COVID-19 pediatric patient. Neurol Sci 2021. [PMID: 34668122 DOI: 10.1007/s10072-021-05670-9] [Reference Citation Analysis]
165 Braune K, Rojas PD, Hofferbert J, Valera Sosa A, Lebedev A, Balzer F, Thun S, Lieber S, Kirchberger V, Poncette AS. Interdisciplinary Online Hackathons as an Approach to Combat the COVID-19 Pandemic: Case Study. J Med Internet Res 2021;23:e25283. [PMID: 33497350 DOI: 10.2196/25283] [Reference Citation Analysis]
166 Thimmulappa RK, Mudnakudu-Nagaraju KK, Shivamallu C, Subramaniam KJT, Radhakrishnan A, Bhojraj S, Kuppusamy G. Antiviral and immunomodulatory activity of curcumin: A case for prophylactic therapy for COVID-19. Heliyon 2021;7:e06350. [PMID: 33655086 DOI: 10.1016/j.heliyon.2021.e06350] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 14.0] [Reference Citation Analysis]
167 Erel Ö, Neşelioğlu S, Ergin Tunçay M, Fırat Oğuz E, Eren F, Akkuş MS, Güner HR, Ateş İ. A sensitive indicator for the severity of COVID-19: thiol. Turk J Med Sci 2021;51:921-8. [PMID: 33306332 DOI: 10.3906/sag-2011-139] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
168 Bahmani M, Chegini R, Ghanbari E, Sheykhsaran E, Shiri Aghbash P, Leylabadlo HE, Moradian E, Kazemzadeh Houjaghan AM, Bannazadeh Baghi H. Severe acute respiratory syndrome coronavirus 2 infection: Role of interleukin-6 and the inflammatory cascade. World J Virol 2022; 11(3): 113-128 [DOI: 10.5501/wjv.v11.i3.113] [Reference Citation Analysis]
169 Hong BS, Kim MR. Interplays between human microbiota and microRNAs in COVID-19 pathogenesis: a literature review. Phys Act Nutr 2021;25:1-7. [PMID: 34315200 DOI: 10.20463/pan.2021.0008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
170 Souza PFN, Mesquita FP, Amaral JL, Landim PGC, Lima KRP, Costa MB, Farias IR, Lima LB, Montenegro RC. The human pandemic coronaviruses on the show: The spike glycoprotein as the main actor in the coronaviruses play. Int J Biol Macromol 2021;179:1-19. [PMID: 33667553 DOI: 10.1016/j.ijbiomac.2021.02.203] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
171 Agrawal H, Das N, Nathani S, Saha S, Saini S, Kakar SS, Roy P. An Assessment on Impact of COVID-19 Infection in a Gender Specific Manner. Stem Cell Rev Rep 2021;17:94-112. [PMID: 33029768 DOI: 10.1007/s12015-020-10048-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
172 Sobska J, Waszkielewicz M, Podleśny-Drabiniok A, Olesiak-Banska J, Krężel W, Matczyszyn K. Gold Nanoclusters Display Low Immunogenic Effect in Microglia Cells. Nanomaterials (Basel) 2021;11:1066. [PMID: 33919336 DOI: 10.3390/nano11051066] [Reference Citation Analysis]
173 Choi YM, Jeong H, Park U, Cho NH, Kim BJ. A Hepatitis B Virus-Derived Peptide Can Inhibit Infection of Human Lung Cells with SARS-CoV-2 in a Type-1 Interferon-Dependent Manner. Viruses 2021;13:1227. [PMID: 34202029 DOI: 10.3390/v13071227] [Reference Citation Analysis]
174 Horspool AM, Kieffer T, Russ BP, DeJong MA, Wolf MA, Karakiozis JM, Hickey BJ, Fagone P, Tacker DH, Bevere JR, Martinez I, Barbier M, Perrotta PL, Damron FH. Interplay of Antibody and Cytokine Production Reveals CXCL13 as a Potential Novel Biomarker of Lethal SARS-CoV-2 Infection. mSphere 2021;6:e01324-20. [PMID: 33472985 DOI: 10.1128/mSphere.01324-20] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
175 Saggam A, Limgaokar K, Borse S, Chavan-Gautam P, Dixit S, Tillu G, Patwardhan B. Withania somnifera (L.) Dunal: Opportunity for Clinical Repurposing in COVID-19 Management. Front Pharmacol 2021;12:623795. [PMID: 34012390 DOI: 10.3389/fphar.2021.623795] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
176 Chen H, Qin R, Huang Z, He L, Luo W, Zheng P, Huang H, Wang H, Sun B. Characteristics of COVID-19 Patients Based on the Results of Nucleic Acid and Specific Antibodies and the Clinical Relevance of Antibody Levels. Front Mol Biosci 2020;7:605862. [PMID: 33585558 DOI: 10.3389/fmolb.2020.605862] [Reference Citation Analysis]
177 de Barros Viana M, Rosário BDA, de Fátima Santana de Nazaré M, Estadella D, Ribeiro DA, Socorro de Barros Viana G. COVID-19 in age-related neurodegenerative diseases: is there a role for vitamin D3 as a possible therapeutic strategy? Rev Neurosci 2021;32:235-47. [PMID: 33185582 DOI: 10.1515/revneuro-2020-0074] [Reference Citation Analysis]
178 Lyu M, Fan G, Xiao G, Wang T, Xu D, Gao J, Ge S, Li Q, Ma Y, Zhang H, Wang J, Cui Y, Zhang J, Zhu Y, Zhang B. Traditional Chinese medicine in COVID-19. Acta Pharm Sin B 2021;11:3337-63. [PMID: 34567957 DOI: 10.1016/j.apsb.2021.09.008] [Reference Citation Analysis]
179 Brosnahan SB, Chen XJC, Chung J, Altshuler D, Islam S, Thomas SV, Winner MD, Greco AA, Divers J, Spiegler P, Sterman DH, Parnia S. Low-Dose Tocilizumab With High-Dose Corticosteroids in Patients Hospitalized for COVID-19 Hypoxic Respiratory Failure Improves Mortality Without Increased Infection Risk. Ann Pharmacother 2021;:10600280211028882. [PMID: 34180274 DOI: 10.1177/10600280211028882] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
180 Kumboyono K, Chomsy IN, Iskandar A, Aryati A, Parwati I, Wihastuti TA. The Potential Predictive Role of Tumour Necrosis Factor-α, Interleukin-1β, and Monocyte Chemoattractant Protein-1 for COVID-19 Patients Survival. IDR 2022;Volume 15:821-9. [DOI: 10.2147/idr.s348392] [Reference Citation Analysis]
181 Karakaş N, Üçüncüoğlu S, Uludağ D, Karaoğlan BS, Shah K, Öztürk G. Mesenchymal Stem Cell-Based COVID-19 Therapy: Bioengineering Perspectives. Cells 2022;11:465. [DOI: 10.3390/cells11030465] [Reference Citation Analysis]
182 Patil P, Shetty P, Kuriakose N, Gollapalli P, Shetty S, Bhandary R, Vishwanatha JK, Ghate SD. Molecular Insights on the Possible Role of Annexin A2 in COVID-19 Pathogenesis and Post-Infection Complications. Int J Mol Sci 2021;22:11028. [PMID: 34681689 DOI: 10.3390/ijms222011028] [Reference Citation Analysis]
183 Virág M, Rottler M, Ocskay K, Leiner T, Horváth B, Blanco DA, Vasquez A, Bucsi L, Sárkány Á, Molnár Z. Extracorporeal Cytokine Removal in Critically Ill COVID-19 Patients: A Case Series. Front Med (Lausanne) 2021;8:760435. [PMID: 34869464 DOI: 10.3389/fmed.2021.760435] [Reference Citation Analysis]
184 Tarris G, de Rougemont A, Estienney MA, Journet J, Lariotte AC, Aubignat D, Rebibou JM, De La Vega MF, Legendre M, Belliot G, Martin L. Chronic kidney disease linked to SARS-CoV-2 infection: a case report. BMC Nephrol 2021;22:278. [PMID: 34376184 DOI: 10.1186/s12882-021-02490-z] [Reference Citation Analysis]
185 Ma D, Liu S, Hu L, He Q, Shi W, Yan D, Cao Y, Zhang G, Wang Z, Wu J, Jiang C. Single-cell RNA sequencing identify SDCBP in ACE2-positive bronchial epithelial cells negatively correlates with COVID-19 severity. J Cell Mol Med 2021;25:7001-12. [PMID: 34137173 DOI: 10.1111/jcmm.16714] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
186 Gallo CG, Fiorino S, Posabella G, Antonacci D, Tropeano A, Pausini E, Pausini C, Guarniero T, Hong W, Giampieri E, Corazza I, Loiacono R, Loggi E, de Biase D, Zippi M, Lari F, Zancanaro M. The function of specialized pro-resolving endogenous lipid mediators, vitamins, and other micronutrients in the control of the inflammatory processes: Possible role in patients with SARS-CoV-2 related infection. Prostaglandins Other Lipid Mediat 2022;:106619. [PMID: 35032665 DOI: 10.1016/j.prostaglandins.2022.106619] [Reference Citation Analysis]
187 Xiong X, Jiao X, Li H, Zeng S, Wang Y, Gao Q. Glucocorticoid benefits the ventilatory function of severe/critical COVID-19 patients. J Infect 2021;82:e33-5. [PMID: 33220384 DOI: 10.1016/j.jinf.2020.11.017] [Reference Citation Analysis]
188 Ferrari D, Locatelli M, Briguglio M, Lombardi G. Is there a link between vitamin D status, SARS-CoV-2 infection risk and COVID-19 severity? Cell Biochem Funct 2021;39:35-47. [PMID: 33137851 DOI: 10.1002/cbf.3597] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
189 Talwar D, Kumar S, Acharya S, Hulkoti V, Annadatha A. Sirolimus in a Renal Transplant Recipient Infected With COVID-19: A Blessing in Disguise? Cureus 2021;13:e17102. [PMID: 34527488 DOI: 10.7759/cureus.17102] [Reference Citation Analysis]
190 Kumar NB. Does COVID-19-related cachexia mimic cancer-related cachexia? Examining mechanisms, clinical biomarkers, and potential targets for clinical management. J Cachexia Sarcopenia Muscle 2021;12:519-22. [PMID: 33554483 DOI: 10.1002/jcsm.12681] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
191 Hudakova N, Hricikova S, Kulkarni A, Bhide M, Kontsekova E, Cizkova D. Fundamental and Advanced Therapies, Vaccine Development against SARS-CoV-2. Pathogens 2021;10:636. [PMID: 34064300 DOI: 10.3390/pathogens10060636] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
192 Liput JR, Jordan K, Patadia R, Kander E. Warm Autoimmune Hemolytic Anemia Associated With Asymptomatic SARS-CoV-2 Infection. Cureus 2021;13:e14101. [PMID: 33927918 DOI: 10.7759/cureus.14101] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
193 Saber S, Alomar SY, Yahya G. Blocking prostanoid receptors switches on multiple immune responses and cascades of inflammatory signaling against larval stages in snail fever. Environ Sci Pollut Res Int 2022. [PMID: 35396684 DOI: 10.1007/s11356-022-20108-1] [Reference Citation Analysis]
194 Rex DAB, Dagamajalu S, Kandasamy RK, Raju R, Prasad TSK. SARS-CoV-2 signaling pathway map: A functional landscape of molecular mechanisms in COVID-19. J Cell Commun Signal 2021. [PMID: 34181169 DOI: 10.1007/s12079-021-00632-4] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
195 Pouladzadeh M, Safdarian M, Eshghi P, Abolghasemi H, Bavani AG, Sheibani B, Moradi Choghakabodi P, Feghhi A, Ghafourian Boroujerdnia M, Forouzan A, Jalali Far MA, Kaydani GA, Rajaei E, Amin M, Torabizadeh M, Yousefi F, Hadaddezfuli R. A randomized clinical trial evaluating the immunomodulatory effect of convalescent plasma on COVID-19-related cytokine storm. Intern Emerg Med 2021. [PMID: 33837906 DOI: 10.1007/s11739-021-02734-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
196 Balta MG, Papathanasiou E, Christopoulos PF. Specialized Pro-Resolving Mediators as Potential Regulators of Inflammatory Macrophage Responses in COVID-19. Front Immunol 2021;12:632238. [PMID: 33717168 DOI: 10.3389/fimmu.2021.632238] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
197 Banday AZ, Vignesh P. Use of tocilizumab in multisystem inflammatory syndrome in children associated with severe acute respiratory syndrome coronavirus 2. J Pediatr 2021;228:315. [PMID: 32979386 DOI: 10.1016/j.jpeds.2020.09.054] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
198 Pan T, Chen R, He X, Yuan Y, Deng X, Li R, Yan H, Yan S, Liu J, Zhang Y, Zhang X, Yu F, Zhou M, Ke C, Ma X, Zhang H. Infection of wild-type mice by SARS-CoV-2 B.1.351 variant indicates a possible novel cross-species transmission route. Signal Transduct Target Ther 2021;6:420. [PMID: 34907154 DOI: 10.1038/s41392-021-00848-1] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
199 Barman A, Sahoo J, Viswanath A, Roy SS, Swarnakar R, Bhattacharjee S. Clinical Features, Laboratory, and Radiological Findings of Patients With Acute Inflammatory Myelopathy After COVID-19 Infection: A Narrative Review. Am J Phys Med Rehabil 2021;100:919-39. [PMID: 34347629 DOI: 10.1097/PHM.0000000000001857] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
200 Kern C, Schöning V, Chaccour C, Hammann F. Modeling of SARS-CoV-2 Treatment Effects for Informed Drug Repurposing. Front Pharmacol 2021;12:625678. [PMID: 33776767 DOI: 10.3389/fphar.2021.625678] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
201 Devi P, Maurya R, Mehta P, Shamim U, Yadav A, Chattopadhyay P, Kanakan A, Khare K, Vasudevan JS, Sahni S, Mishra P, Tyagi A, Jha S, Budhiraja S, Tarai B, Pandey R. Increased Abundance of Achromobacter xylosoxidans and Bacillus cereus in Upper Airway Transcriptionally Active Microbiome of COVID-19 Mortality Patients Indicates Role of Co-Infections in Disease Severity and Outcome. Microbiol Spectr 2022;:e0231121. [PMID: 35579429 DOI: 10.1128/spectrum.02311-21] [Reference Citation Analysis]
202 Do T, Guran R, Jarosova R, Ondrackova P, Sladek Z, Faldyna M, Adam V, Zitka O. MALDI MSI Reveals the Spatial Distribution of Protein Markers in Tracheobronchial Lymph Nodes and Lung of Pigs after Respiratory Infection. Molecules 2020;25:E5723. [PMID: 33287430 DOI: 10.3390/molecules25235723] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
203 [DOI: 10.1101/2020.12.04.20242115] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
204 Morgulchik N, Athanasopoulou F, Chu E, Lam Y, Kamaly N. Potential therapeutic approaches for targeted inhibition of inflammatory cytokines following COVID-19 infection-induced cytokine storm. Interface Focus 2022;12:20210006. [PMID: 34956607 DOI: 10.1098/rsfs.2021.0006] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
205 Capitani N, Patrussi L, Baldari CT. Nature vs. Nurture: The Two Opposing Behaviors of Cytotoxic T Lymphocytes in the Tumor Microenvironment. Int J Mol Sci 2021;22:11221. [PMID: 34681881 DOI: 10.3390/ijms222011221] [Reference Citation Analysis]
206 Cavalli G, Farina N, Campochiaro C, De Luca G, Della-Torre E, Tomelleri A, Dagna L. Repurposing of Biologic and Targeted Synthetic Anti-Rheumatic Drugs in COVID-19 and Hyper-Inflammation: A Comprehensive Review of Available and Emerging Evidence at the Peak of the Pandemic. Front Pharmacol 2020;11:598308. [PMID: 33442386 DOI: 10.3389/fphar.2020.598308] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
207 Ning Q, Wu D, Wang X, Xi D, Chen T, Chen G, Wang H, Lu H, Wang M, Zhu L, Hu J, Liu T, Ma K, Han M, Luo X. The mechanism underlying extrapulmonary complications of the coronavirus disease 2019 and its therapeutic implication. Signal Transduct Target Ther 2022;7:57. [PMID: 35197452 DOI: 10.1038/s41392-022-00907-1] [Reference Citation Analysis]
208 Yin J, Li C, Ye C, Ruan Z, Liang Y, Li Y, Wu J, Luo Z. Advances in the development of therapeutic strategies against COVID-19 and perspectives in the drug design for emerging SARS-CoV-2 variants. Computational and Structural Biotechnology Journal 2022. [DOI: 10.1016/j.csbj.2022.01.026] [Reference Citation Analysis]
209 Sharma P, Pandey AK, Bhattacharyya DK. Determining crucial genes associated with COVID-19 based on COPD Findings✶,✶✶. Comput Biol Med 2021;128:104126. [PMID: 33260035 DOI: 10.1016/j.compbiomed.2020.104126] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
210 de Almeida Chuffa LG, Freire PP, Dos Santos Souza J, de Mello MC, de Oliveira Neto M, Carvalho RF. Aging whole blood transcriptome reveals candidate genes for SARS-CoV-2-related vascular and immune alterations. J Mol Med (Berl) 2021. [PMID: 34741638 DOI: 10.1007/s00109-021-02161-4] [Reference Citation Analysis]
211 Danwang C, Noubiap JJ, Robert A, Yombi JC. Outcomes of patients with HIV and COVID-19 co-infection: a systematic review and meta-analysis. AIDS Res Ther 2022;19:3. [PMID: 35031068 DOI: 10.1186/s12981-021-00427-y] [Reference Citation Analysis]
212 Derakhshani A, Hemmat N, Asadzadeh Z, Ghaseminia M, Shadbad MA, Jadideslam G, Silvestris N, Racanelli V, Baradaran B. Arginase 1 (Arg1) as an Up-Regulated Gene in COVID-19 Patients: A Promising Marker in COVID-19 Immunopathy. J Clin Med 2021;10:1051. [PMID: 33806290 DOI: 10.3390/jcm10051051] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
213 Lee AC, Castaneda G, Li WT, Chen C, Shende N, Chakladar J, Taub PR, Chang EY, Ongkeko WM. COVID-19 Severity Potentially Modulated by Cardiovascular-Disease-Associated Immune Dysregulation. Viruses 2021;13:1018. [PMID: 34071557 DOI: 10.3390/v13061018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
214 Taglauer ES, Dhole Y, Boateng J, Snyder-Cappione J, Parker SE, Clarke K, Juttukonda L, Devera J, Hunnewell J, Barnett E, Jia H, Yarrington C, Sabharwal V, Wachman EM. Evaluation of maternal-infant dyad inflammatory cytokines in pregnancies affected by maternal SARS-CoV-2 infection in early and late gestation. J Perinatol 2022. [PMID: 35449446 DOI: 10.1038/s41372-022-01391-9] [Reference Citation Analysis]
215 Angioni R, Sasset L, Cioccarelli C, Sánchez-rodríguez R, Bertoldi N, Putaggio CC, Viola A, Cattelan A, Molon B. COVID-19 Vaccination Limits Systemic Danger Signals in SARS-CoV-2 Infected Patients. Viruses 2022;14:565. [DOI: 10.3390/v14030565] [Reference Citation Analysis]
216 Escobedo RA, Singh DK, Kaushal D. Understanding COVID-19: From Dysregulated Immunity to Vaccination Status Quo. Front Immunol 2021;12:765349. [PMID: 34858417 DOI: 10.3389/fimmu.2021.765349] [Reference Citation Analysis]
217 Ahmad S, Hatmal MM, Lambuk L, Al-Hatamleh MAI, Alshaer W, Mohamud R. The role of TNFR2+ Tregs in COVID-19: An overview and a potential therapeutic strategy. Life Sci 2021;286:120063. [PMID: 34673116 DOI: 10.1016/j.lfs.2021.120063] [Reference Citation Analysis]
218 Theoharides TC. Ways to Address Perinatal Mast Cell Activation and Focal Brain Inflammation, including Response to SARS-CoV-2, in Autism Spectrum Disorder. J Pers Med 2021;11:860. [PMID: 34575637 DOI: 10.3390/jpm11090860] [Reference Citation Analysis]
219 Dong X, Wang C, Liu X, Gao W, Bai X, Li Z. Lessons Learned Comparing Immune System Alterations of Bacterial Sepsis and SARS-CoV-2 Sepsis. Front Immunol 2020;11:598404. [PMID: 33329592 DOI: 10.3389/fimmu.2020.598404] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
220 Pinski AN, Steffen TL, Zulu MZ, George SL, Dickson A, Tifrea D, Maroney KJ, Tedeschi N, Zhang Y, Scheuermann RH, Pinto AK, Brien JD, Messaoudi I. Corticosteroid treatment in COVID-19 modulates host inflammatory responses and transcriptional signatures of immune dysregulation. J Leukoc Biol 2021. [PMID: 34730254 DOI: 10.1002/JLB.4COVA0121-084RR] [Reference Citation Analysis]
221 Houshmandfar S, Saeedi-Boroujeni A, Rashno M, Khodadadi A, Mahmoudian-Sani MR. miRNA-223 as a regulator of inflammation and NLRP3 inflammasome, the main fragments in the puzzle of immunopathogenesis of different inflammatory diseases and COVID-19. Naunyn Schmiedebergs Arch Pharmacol 2021;394:2187-95. [PMID: 34590186 DOI: 10.1007/s00210-021-02163-6] [Reference Citation Analysis]
222 Ho JSY, Mok BW, Campisi L, Jordan T, Yildiz S, Parameswaran S, Wayman JA, Gaudreault NN, Meekins DA, Indran SV, Morozov I, Trujillo JD, Fstkchyan YS, Rathnasinghe R, Zhu Z, Zheng S, Zhao N, White K, Ray-Jones H, Malysheva V, Thiecke MJ, Lau SY, Liu H, Zhang AJ, Lee AC, Liu WC, Jangra S, Escalera A, Aydillo T, Melo BS, Guccione E, Sebra R, Shum E, Bakker J, Kaufman DA, Moreira AL, Carossino M, Balasuriya UBR, Byun M, Albrecht RA, Schotsaert M, Garcia-Sastre A, Chanda SK, Miraldi ER, Jeyasekharan AD, TenOever BR, Spivakov M, Weirauch MT, Heinz S, Chen H, Benner C, Richt JA, Marazzi I. TOP1 inhibition therapy protects against SARS-CoV-2-induced lethal inflammation. Cell 2021;184:2618-2632.e17. [PMID: 33836156 DOI: 10.1016/j.cell.2021.03.051] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
223 Gil-etayo FJ, Garcinuño S, Utrero-rico A, Cabrera-marante O, Arroyo-sanchez D, Mancebo E, Pleguezuelo DE, Rodríguez-frías E, Allende LM, Morales-pérez P, Castro-panete MJ, Lalueza A, Lumbreras C, Paz-artal E, Serrano A. An Early Th1 Response Is a Key Factor for a Favorable COVID-19 Evolution. Biomedicines 2022;10:296. [DOI: 10.3390/biomedicines10020296] [Reference Citation Analysis]
224 Wieczfinska J, Kleniewska P, Pawliczak R, Kouretas D. Oxidative Stress-Related Mechanisms in SARS-CoV-2 Infections. Oxidative Medicine and Cellular Longevity 2022;2022:1-15. [DOI: 10.1155/2022/5589089] [Reference Citation Analysis]
225 Niles MA, Gogesch P, Kronhart S, Ortega Iannazzo S, Kochs G, Waibler Z, Anzaghe M. Macrophages and Dendritic Cells Are Not the Major Source of Pro-Inflammatory Cytokines Upon SARS-CoV-2 Infection. Front Immunol 2021;12:647824. [PMID: 34122407 DOI: 10.3389/fimmu.2021.647824] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
226 Pelletier AN, Sekaly RP, Tomalka JA. Translating known drivers of COVID-19 disease severity to design better SARS-CoV-2 vaccines. Curr Opin Virol 2021;52:89-101. [PMID: 34902803 DOI: 10.1016/j.coviro.2021.11.012] [Reference Citation Analysis]
227 de Carvalho Lima EN, Octaviano ALM, Piqueira JRC, Diaz RS, Justo JF. Coronavirus and Carbon Nanotubes: Seeking Immunological Relationships to Discover Immunotherapeutic Possibilities. IJN 2022;Volume 17:751-81. [DOI: 10.2147/ijn.s341890] [Reference Citation Analysis]
228 Makker J, Mantri N, Patel HK, Abbas H, Baiomi A, Sun H, Choi Y, Chilimuri S, Nayudu SK. The Incidence and Mortality Impact of Gastrointestinal Bleeding in Hospitalized COVID-19 Patients. Clin Exp Gastroenterol 2021;14:405-11. [PMID: 34675588 DOI: 10.2147/CEG.S318149] [Reference Citation Analysis]
229 Hertanto DM, Wiratama BS, Sutanto H, Wungu CDK. Immunomodulation as a Potent COVID-19 Pharmacotherapy: Past, Present and Future. J Inflamm Res 2021;14:3419-28. [PMID: 34321903 DOI: 10.2147/JIR.S322831] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
230 Liskova A, Samec M, Koklesova L, Samuel SM, Zhai K, Al-Ishaq RK, Abotaleb M, Nosal V, Kajo K, Ashrafizadeh M, Zarrabi A, Brockmueller A, Shakibaei M, Sabaka P, Mozos I, Ullrich D, Prosecky R, La Rocca G, Caprnda M, Büsselberg D, Rodrigo L, Kruzliak P, Kubatka P. Flavonoids against the SARS-CoV-2 induced inflammatory storm. Biomed Pharmacother 2021;138:111430. [PMID: 33662680 DOI: 10.1016/j.biopha.2021.111430] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 14.0] [Reference Citation Analysis]
231 Al-Fahad D, Majeed K, Al-Naqshbandi A, Al-Amery A, Fahad Alharbi B. The Cytokines Responses against Parvovirus B19 in Miscarriage Women and the Susceptibility of their RhD Blood Type to Contract Parvovirus B19 in South of Iraq. Rep Biochem Mol Biol 2021;10:462-70. [PMID: 34981024 DOI: 10.52547/rbmb.10.3.462] [Reference Citation Analysis]
232 El-Tallawy SN, Nalamasu R, Pergolizzi JV, Gharibo C. Pain Management During the COVID-19 Pandemic. Pain Ther 2020;9:453-66. [PMID: 32840756 DOI: 10.1007/s40122-020-00190-4] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 9.5] [Reference Citation Analysis]
233 Kovarik JJ, Kämpf AK, Gasser F, Herdina AN, Breuer M, Kaltenecker CC, Wahrmann M, Haindl S, Mayer F, Traby L, Touzeau-Roemer V, Grabmeier-Pfistershammer K, Kussmann M, Robak O, Willschke H, Ay C, Säemann MD, Schmetterer KG, Strassl R. Identification of Immune Activation Markers in the Early Onset of COVID-19 Infection. Front Cell Infect Microbiol 2021;11:651484. [PMID: 34540715 DOI: 10.3389/fcimb.2021.651484] [Reference Citation Analysis]
234 Chen PK, Lan JL, Huang PH, Hsu JL, Chang CK, Tien N, Lin HJ, Chen DY. Interleukin-18 Is a Potential Biomarker to Discriminate Active Adult-Onset Still's Disease From COVID-19. Front Immunol 2021;12:719544. [PMID: 34367188 DOI: 10.3389/fimmu.2021.719544] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
235 Ye CH, Hsu WL, Peng GR, Yu WC, Lin WC, Hu S, Yu SH. Role of the Immune Microenvironment in SARS-CoV-2 Infection. Cell Transplant 2021;30:9636897211010632. [PMID: 33949207 DOI: 10.1177/09636897211010632] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
236 Kapila YL. Oral health's inextricable connection to systemic health: Special populations bring to bear multimodal relationships and factors connecting periodontal disease to systemic diseases and conditions. Periodontol 2000 2021;87:11-6. [PMID: 34463994 DOI: 10.1111/prd.12398] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
237 Michalakis K, Ilias I. COVID-19 and hyperglycemia/diabetes. World J Diabetes 2021; 12(5): 642-650 [PMID: 33995851 DOI: 10.4239/wjd.v12.i5.642] [Reference Citation Analysis]
238 Sinha R, Anand S, Singh D, Tripathi S, Shukla P, Singh S, Srivastava P. Bioprocessing strategies for microbial production and purification of immunosuppressants: an insight for process intensification. Chemical Engineering and Processing - Process Intensification 2022. [DOI: 10.1016/j.cep.2022.108797] [Reference Citation Analysis]
239 Chen Y, Zhou X, Yan H, Huang H, Li S, Jiang Z, Zhao J, Meng Z. CANPT Score: A Tool to Predict Severe COVID-19 on Admission. Front Med (Lausanne) 2021;8:608107. [PMID: 33681245 DOI: 10.3389/fmed.2021.608107] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
240 Barcellini W, Giannotta JA, Fattizzo B. Are Patients With Autoimmune Cytopenias at Higher Risk of COVID-19 Pneumonia? The Experience of a Reference Center in Northern Italy and Review of the Literature. Front Immunol 2020;11:609198. [PMID: 33574816 DOI: 10.3389/fimmu.2020.609198] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
241 Selvarajan RS, Gopinath SCB, Zin NM, Hamzah AA. Infection-Mediated Clinical Biomarkers for a COVID-19 Electrical Biosensing Platform. Sensors (Basel) 2021;21:3829. [PMID: 34205852 DOI: 10.3390/s21113829] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
242 Huntington KE, Louie AD, Lee CG, Elias JA, Ross EA, El-Deiry WS. Cytokine ranking via mutual information algorithm correlates cytokine profiles with presenting disease severity in patients infected with SARS-CoV-2. Elife 2021;10:e64958. [PMID: 33443016 DOI: 10.7554/eLife.64958] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
243 Puzyrenko A, Felix JC, Sun Y, Rui H, Sheinin Y. Acute SARS-CoV-2 pneumonitis with cytotoxic CD8 positive T-lymphocytes: Case report and review of the literature. Pathol Res Pract 2021;220:153380. [PMID: 33676105 DOI: 10.1016/j.prp.2021.153380] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
244 Chan CEZ, Seah SGK, Chye H, Massey S, Torres M, Lim APC, Wong SKK, Neo JJY, Wong PS, Lim JH, Loh GSL, Wang D, Boyd-Kirkup JD, Guan S, Thakkar D, Teo GH, Purushotorman K, Hutchinson PE, Young BE, Low JG, MacAry PA, Hentze H, Prativadibhayankara VS, Ethirajulu K, Comer JE, Tseng CK, Barrett ADT, Ingram PJ, Brasel T, Hanson BJ. The Fc-mediated effector functions of a potent SARS-CoV-2 neutralizing antibody, SC31, isolated from an early convalescent COVID-19 patient, are essential for the optimal therapeutic efficacy of the antibody. PLoS One 2021;16:e0253487. [PMID: 34161386 DOI: 10.1371/journal.pone.0253487] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
245 Banerjee A. COVID-19: Fractured society and future challenges. Ind Psychiatry J 2021;30:S3-4. [PMID: 34908655 DOI: 10.4103/0972-6748.328780] [Reference Citation Analysis]
246 Ballow M, Haga CL. Why Do Some People Develop Serious COVID-19 Disease After Infection, While Others Only Exhibit Mild Symptoms? J Allergy Clin Immunol Pract 2021;9:1442-8. [PMID: 33486141 DOI: 10.1016/j.jaip.2021.01.012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
247 Coke CJ, Davison B, Fields N, Fletcher J, Rollings J, Roberson L, Challagundla KB, Sampath C, Cade J, Farmer-Dixon C, Gangula PR. SARS-CoV-2 Infection and Oral Health: Therapeutic Opportunities and Challenges. J Clin Med 2021;10:E156. [PMID: 33466289 DOI: 10.3390/jcm10010156] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
248 Nossent EJ, Schuurman AR, Reijnders TDY, Saris A, Jongerius I, Blok SG, de Vries H, Duitman J, Vonk Noordegraaf A, Meijboom LJ, Lutter R, Heunks L, Bogaard HJ, van der Poll T. Pulmonary Procoagulant and Innate Immune Responses in Critically Ill COVID-19 Patients. Front Immunol 2021;12:664209. [PMID: 34054832 DOI: 10.3389/fimmu.2021.664209] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
249 Kumawat A, Namsani S, Pramanik D, Roy S, Singh JK. Integrated docking and enhanced sampling-based selection of repurposing drugs for SARS-CoV-2 by targeting host dependent factors. J Biomol Struct Dyn 2021;:1-12. [PMID: 34155961 DOI: 10.1080/07391102.2021.1937319] [Reference Citation Analysis]
250 Hopkins C, Lechien JR, Saussez S. More that ACE2? NRP1 may play a central role in the underlying pathophysiological mechanism of olfactory dysfunction in COVID-19 and its association with enhanced survival. Med Hypotheses 2021;146:110406. [PMID: 33246692 DOI: 10.1016/j.mehy.2020.110406] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
251 Banerjee A, Ganguly U, Saha S, Chakrabarti S, Saini RV, Rawal RK, Saso L, Chakrabarti S. Vitamin D and immuno-pathology of COVID-19: many interactions but uncertain therapeutic benefits. Expert Rev Anti Infect Ther 2021;:1-14. [PMID: 33739215 DOI: 10.1080/14787210.2021.1905519] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
252 Martínez-García M, Hernández-Lemus E. Periodontal Inflammation and Systemic Diseases: An Overview. Front Physiol 2021;12:709438. [PMID: 34776994 DOI: 10.3389/fphys.2021.709438] [Reference Citation Analysis]
253 Liu BM, Martins TB, Peterson LK, Hill HR. Clinical significance of measuring serum cytokine levels as inflammatory biomarkers in adult and pediatric COVID-19 cases: A review. Cytokine 2021;142:155478. [PMID: 33667962 DOI: 10.1016/j.cyto.2021.155478] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
254 Hamed DM, Belhoul KM, Al Maazmi NA, Ghayoor F, Moin M, Al Suwaidi M, Narainen M, Makki M, AbdulRahman M. Intravenous methylprednisolone with or without tocilizumab in patients with severe COVID-19 pneumonia requiring oxygen support: A prospective comparison. J Infect Public Health 2021;14:985-9. [PMID: 34153729 DOI: 10.1016/j.jiph.2021.06.003] [Reference Citation Analysis]
255 Kornitzer J, Johnson J, Yang M, Pecor KW, Cohen N, Jiang C, Ming X. A Systematic Review of Characteristics Associated with COVID-19 in Children with Typical Presentation and with Multisystem Inflammatory Syndrome. Int J Environ Res Public Health 2021;18:8269. [PMID: 34444014 DOI: 10.3390/ijerph18168269] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
256 Schultze JL, Aschenbrenner AC. COVID-19 and the human innate immune system. Cell 2021;184:1671-92. [PMID: 33743212 DOI: 10.1016/j.cell.2021.02.029] [Cited by in Crossref: 49] [Cited by in F6Publishing: 52] [Article Influence: 49.0] [Reference Citation Analysis]
257 Alsagaff MY, Mulia EPB, Maghfirah I, Luke K, Nugraha D, Rachmi DA, Septianda I, A'yun MQ. Association of calcium channel blocker use with clinical outcome of COVID-19: A meta-analysis. Diabetes Metab Syndr 2021;15:102210. [PMID: 34298269 DOI: 10.1016/j.dsx.2021.102210] [Reference Citation Analysis]
258 Hamoda AM, Fayed B, Ashmawy NS, El-Shorbagi AA, Hamdy R, Soliman SSM. Marine Sponge is a Promising Natural Source of Anti-SARS-CoV-2 Scaffold. Front Pharmacol 2021;12:666664. [PMID: 34079462 DOI: 10.3389/fphar.2021.666664] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
259 Scolari FL, Schneider D, Fogazzi DV, Gus M, Rover MM, Bonatto MG, de Araújo GN, Zimerman A, Sganzerla D, Goldraich LA, Teixeira C, Friedman G, Polanczyk CA, Rohde LE, Rosa RG, Wainstein RV. Association between serum lactate levels and mortality in patients with cardiogenic shock receiving mechanical circulatory support: a multicenter retrospective cohort study. BMC Cardiovasc Disord 2020;20:496. [PMID: 33234107 DOI: 10.1186/s12872-020-01785-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
260 Souza PFN, Mesquita FP, Amaral JL, Landim PGC, Lima KRP, Costa MB, Farias IR, Belém MO, Pinto YO, Moreira HHT, Magalhaes ICL, Castelo-Branco DSCM, Montenegro RC, de Andrade CR. The spike glycoproteins of SARS-CoV-2: A review of how mutations of spike glycoproteins have driven the emergence of variants with high transmissibility and immune escape. Int J Biol Macromol 2022:S0141-8130(22)00528-1. [PMID: 35300999 DOI: 10.1016/j.ijbiomac.2022.03.058] [Reference Citation Analysis]
261 Murugan AK, Alzahrani AS. SARS-CoV-2: Emerging Role in the Pathogenesis of Various Thyroid Diseases. J Inflamm Res 2021;14:6191-221. [PMID: 34853527 DOI: 10.2147/JIR.S332705] [Reference Citation Analysis]
262 de Andrade-Junior MC, de Salles ICD, de Brito CMM, Pastore-Junior L, Righetti RF, Yamaguti WP. Skeletal Muscle Wasting and Function Impairment in Intensive Care Patients With Severe COVID-19. Front Physiol 2021;12:640973. [PMID: 33776796 DOI: 10.3389/fphys.2021.640973] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
263 Fu Z, Zhang J. Molecular hydrogen is a promising therapeutic agent for pulmonary disease. J Zhejiang Univ Sci B 2022;23:102-22. [PMID: 35187885 DOI: 10.1631/jzus.B2100420] [Reference Citation Analysis]
264 Delshad M, Tavakolinia N, Pourbagheri-Sigaroodi A, Safaroghli-Azar A, Bagheri N, Bashash D. The contributory role of lymphocyte subsets, pathophysiology of lymphopenia and its implication as prognostic and therapeutic opportunity in COVID-19. Int Immunopharmacol 2021;95:107586. [PMID: 33765611 DOI: 10.1016/j.intimp.2021.107586] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
265 Li C, Ou R, Wei Q, Shang H. Carnitine and COVID-19 Susceptibility and Severity: A Mendelian Randomization Study. Front Nutr 2021;8:780205. [PMID: 34901126 DOI: 10.3389/fnut.2021.780205] [Reference Citation Analysis]
266 Feyaerts D, Hedou J, Gillard J, Chen H, Tsai ES, Peterson LS, Ando K, Manohar M, Do E, Dhondalay GKR, Fitzpatrick J, Artandi M, Chang I, Snow TT, Chinthrajah RS, Warren CM, Wittman R, Meyerowitz JG, Ganio EA, Stelzer IA, Han X, Verdonk F, Gaudilliere DK, Mukherjee N, Tsai AS, Rumer KK, Jiang SJ, Valdes-Ferrer SI, Kelly JD, Furman D, Aghaeepour N, Angst MS, Boyd SD, Pinsky BA, Nolan GP, Nadeau KC, Gaudilliere B, McIlwain DR. Integrated plasma proteomic and single-cell immune signaling network signatures demarcate mild, moderate, and severe COVID-19. bioRxiv 2021:2021. [PMID: 33594362 DOI: 10.1101/2021.02.09.430269] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
267 Heidarpour M, Abhari AP, Sadeghpour N, Shafie D, Sarokhani D. Prediabetes and COVID-19 severity, an underestimated risk factor: A systematic review and meta-analysis. Diabetes Metab Syndr 2021;15:102307. [PMID: 34731820 DOI: 10.1016/j.dsx.2021.102307] [Reference Citation Analysis]
268 Zhang Z, Zhang X, Bi K, He Y, Yan W, Yang CS, Zhang J. Potential protective mechanisms of green tea polyphenol EGCG against COVID-19. Trends Food Sci Technol 2021;114:11-24. [PMID: 34054222 DOI: 10.1016/j.tifs.2021.05.023] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
269 Hashemipour S, Shahsavari P, Kiani S, Badri M, Ghobadi A, Hadizadeh Khairkhahan SMR, Tariverdi A. Wide Spectrum of Thyroid Function Tests in COVID-19: From Nonthyroidal Illness to Isolated Hyperthyroxinemia. Int J Endocrinol Metab 2022;20. [DOI: 10.5812/ijem.120709] [Reference Citation Analysis]
270 Martonik D, Parfieniuk-Kowerda A, Rogalska M, Flisiak R. The Role of Th17 Response in COVID-19. Cells 2021;10:1550. [PMID: 34205262 DOI: 10.3390/cells10061550] [Reference Citation Analysis]
271 Sunkara H, Dewan SMR. Coronavirus disease-2019: A review on the disease exacerbation via cytokine storm and concurrent management. Int Immunopharmacol 2021;99:108049. [PMID: 34426104 DOI: 10.1016/j.intimp.2021.108049] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
272 Khalili M, Chegeni M, Javadi S, Farokhnia M, Sharifi H, Karamouzian M. Therapeutic interventions for COVID-19: a living overview of reviews. Ther Adv Respir Dis 2020;14:1753466620976021. [PMID: 33326318 DOI: 10.1177/1753466620976021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
273 Jafari A, Sadeghpour S, Ghasemnejad-Berenji H, Pashapour S, Ghasemnejad-Berenji M. Potential Antioxidative, Anti-inflammatory and Immunomodulatory Effects of Ghrelin, an Endogenous Peptide from the Stomach in SARS-CoV2 Infection. Int J Pept Res Ther 2021;:1-9. [PMID: 33880115 DOI: 10.1007/s10989-021-10217-9] [Reference Citation Analysis]
274 Davis J, Umeh U, Saba R. Treatment of SARS-CoV-2 (COVID-19): A safety perspective. World J Pharmacol 2021; 10(1): 1-32 [DOI: 10.5497/wjp.v10.i1.1] [Reference Citation Analysis]
275 Lv Z, Shi Y, Bassi GS, Chen Y, Yin L, Wang Y, Ulloa L, Yang Y, Xu Y. Electroacupuncture at ST36 (Zusanli) Prevents T-Cell Lymphopenia and Improves Survival in Septic Mice. JIR 2022;Volume 15:2819-33. [DOI: 10.2147/jir.s361466] [Reference Citation Analysis]
276 Law MF, Ho R, Law KWT, Cheung CKM. Gastrointestinal and hepatic side effects of potential treatment for COVID-19 and vaccination in patients with chronic liver diseases. World J Hepatol 2021; 13(12): 1850-1874 [DOI: 10.4254/wjh.v13.i12.1850] [Reference Citation Analysis]
277 Ghosh A, Sarkar A, Paul P, Patel P. The rise in cases of mucormycosis, candidiasis and aspergillosis amidst COVID19. Fungal Biol Rev 2021;38:67-91. [PMID: 34548877 DOI: 10.1016/j.fbr.2021.09.003] [Reference Citation Analysis]
278 Limen RY, Sedono R, Sugiarto A, Hariyanto TI. Janus kinase (JAK)-inhibitors and coronavirus disease 2019 (Covid-19) outcomes: a systematic review and meta-analysis. Expert Rev Anti Infect Ther 2021;:1-10. [PMID: 34538216 DOI: 10.1080/14787210.2021.1982695] [Reference Citation Analysis]
279 Kaliamurthi S, Selvaraj G, Selvaraj C, Singh SK, Wei DQ, Peslherbe GH. Structure-Based Virtual Screening Reveals Ibrutinib and Zanubrutinib as Potential Repurposed Drugs against COVID-19. Int J Mol Sci 2021;22:7071. [PMID: 34209188 DOI: 10.3390/ijms22137071] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
280 Hussain A, Rafeeq H, Asif HM, Shabbir S, Bilal M, Mulla SI, Franco M, Iqbal HMN. Current scenario of COVID-19 vaccinations and immune response along with antibody titer in vaccinated inhabitants of different countries. Int Immunopharmacol 2021;99:108050. [PMID: 34426120 DOI: 10.1016/j.intimp.2021.108050] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
281 Mu Y, McManus DP, Hou N, Cai P. Schistosome Infection and Schistosome-Derived Products as Modulators for the Prevention and Alleviation of Immunological Disorders. Front Immunol 2021;12:619776. [PMID: 33692793 DOI: 10.3389/fimmu.2021.619776] [Reference Citation Analysis]
282 Gupta A, Gupta GS. Status of mannose-binding lectin (MBL) and complement system in COVID-19 patients and therapeutic applications of antiviral plant MBLs. Mol Cell Biochem 2021;476:2917-42. [PMID: 33745077 DOI: 10.1007/s11010-021-04107-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
283 Kazakou P, Paschou SA, Psaltopoulou T, Gavriatopoulou M, Korompoki E, Stefanaki K, Kanouta F, Kassi GN, Dimopoulos MA, Mitrakou A. Early and late endocrine complications of COVID-19. Endocr Connect 2021;10:R229-39. [PMID: 34424853 DOI: 10.1530/EC-21-0184] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
284 Tanwar O, Soni A, Prajapat P, Shivhare T, Pandey P, Samaiya PK, Pandey SP, Kar P. Ethyl Pyruvate as a Potential Defense Intervention against Cytokine Storm in COVID-19? ACS Omega 2021;6:7754-60. [PMID: 33778286 DOI: 10.1021/acsomega.1c00157] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
285 Dadkhah M, Talei S, Doostkamel D, Molaei S, Rezaei N. The impact of COVID-19 on diagnostic biomarkers in neuropsychiatric and neuroimmunological diseases: a review. Rev Neurosci 2021. [PMID: 34087964 DOI: 10.1515/revneuro-2020-0154] [Reference Citation Analysis]
286 Weiwei D, Bei W, Hong W, Cailan W, Hailin S, Donghong X, Xiaolai W, Zhaohu H, Shijun L, Jian T, Qiang J. Thyroid Hormone Changes in the Northern Area of Tianjin during the COVID-19 Pandemic. Int J Endocrinol 2022;2022:5720875. [PMID: 35013681 DOI: 10.1155/2022/5720875] [Reference Citation Analysis]
287 Kircheis R, Schuster M, Planz O. COVID-19: Mechanistic Model of the African Paradox Supports the Central Role of the NF-κB Pathway. Viruses 2021;13:1887. [PMID: 34578468 DOI: 10.3390/v13091887] [Reference Citation Analysis]
288 Cleto-Yamane TL, Rodrigues-Santos G, de Magalhães-Barbosa MC, Moura PG, Vasconcelos RD, Gouveia JLS, de Oliveira AL, Ferreira FC, Shalders AL, de Oliveira MBG, Lima-Setta F, da Cunha AJLA, Prata-Barbosa A. Screening of COVID-19 in outpatient children with cancer or solid organ transplantation: preliminary report. Eur J Pediatr 2021;180:3237-41. [PMID: 33768332 DOI: 10.1007/s00431-021-04044-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
289 Yang Y, Yan M. Mechanisms of Cardiovascular System Injury Induced by COVID-19 in Elderly Patients With Cardiovascular History. Front Cardiovasc Med 2022;9:859505. [DOI: 10.3389/fcvm.2022.859505] [Reference Citation Analysis]
290 Poland GA, Ovsyannikova IG, Kennedy RB. SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates. Lancet 2020;396:1595-606. [PMID: 33065034 DOI: 10.1016/S0140-6736(20)32137-1] [Cited by in Crossref: 225] [Cited by in F6Publishing: 135] [Article Influence: 112.5] [Reference Citation Analysis]
291 Min J, Sempionatto JR, Teymourian H, Wang J, Gao W. Wearable electrochemical biosensors in North America. Biosensors and Bioelectronics 2021;172:112750. [DOI: 10.1016/j.bios.2020.112750] [Cited by in Crossref: 32] [Cited by in F6Publishing: 20] [Article Influence: 32.0] [Reference Citation Analysis]
292 Abdrabbo M, Birch CM, Brandt M, Cicigoi KA, Coffey SJ, Dolan CC, Dvorak H, Gehrke AC, Gerzema AEL, Hansen A, Henseler EJ, Huelsbeck AC, LaBerge B, Leavens CM, Le CN, Lindquist AC, Ludwig RK, Reynolds JH, Severson NJ, Sherman BA, Sillman HW, Smith MA, Smith MA, Snortheim MJ, Svaren LM, Vanderpas EC, Wackett MJ, Wozney AJ, Bhattacharyya S, Hati S. Vitamin D and COVID-19: A review on the role of vitamin D in preventing and reducing the severity of COVID-19 infection. Protein Sci 2021;30:2206-20. [PMID: 34558135 DOI: 10.1002/pro.4190] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
293 Aemaz Ur Rehman M, Farooq H, Ali MM, Ebaad Ur Rehman M, Dar QA, Hussain A. The Association of Subacute Thyroiditis with COVID-19: a Systematic Review. SN Compr Clin Med 2021;:1-13. [PMID: 33942028 DOI: 10.1007/s42399-021-00912-5] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
294 Butler DL, Gildersleeve JC. Abnormal antibodies to self-carbohydrates in SARS-CoV-2 infected patients. bioRxiv 2020:2020. [PMID: 33083799 DOI: 10.1101/2020.10.15.341479] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
295 Rutkowska E, Kwiecień I, Żabicka M, Maliborski A, Raniszewska A, Kłos K, Urbańska W, Klajnowicz I, Rzepecki P, Chciałowski A. Cytokines and Leukocytes Subpopulations Profile in SARS-CoV-2 Patients Depending on the CT Score Severity. Viruses 2021;13:880. [PMID: 34064802 DOI: 10.3390/v13050880] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
296 von Massow G, Oh S, Lam A, Gustafsson K. Gamma Delta T Cells and Their Involvement in COVID-19 Virus Infections. Front Immunol 2021;12:741218. [PMID: 34777353 DOI: 10.3389/fimmu.2021.741218] [Reference Citation Analysis]
297 Tang X, Cai L, Meng Y, Xu J, Lu C, Yang J. Indicator Regularized Non-Negative Matrix Factorization Method-Based Drug Repurposing for COVID-19. Front Immunol 2020;11:603615. [PMID: 33584672 DOI: 10.3389/fimmu.2020.603615] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
298 Grant WB, Lahore H, Rockwell MS. The Benefits of Vitamin D Supplementation for Athletes: Better Performance and Reduced Risk of COVID-19. Nutrients 2020;12:E3741. [PMID: 33291720 DOI: 10.3390/nu12123741] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
299 Hosseini SM, Abrishami M, Zamani G, Hemmati A, Momtahen S, Hassani M, Omidtabrizi A. Acute Bilateral Neuroretinitis and Panuveitis in A Patient with Coronavirus Disease 2019: A Case Report. Ocul Immunol Inflamm 2021;:1-4. [PMID: 33830840 DOI: 10.1080/09273948.2021.1894457] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
300 Zhang S, Amahong K, Zhang C, Li F, Gao J, Qiu Y, Zhu F. RNA-RNA interactions between SARS-CoV-2 and host benefit viral development and evolution during COVID-19 infection. Brief Bioinform 2021:bbab397. [PMID: 34585235 DOI: 10.1093/bib/bbab397] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
301 Shi Q, Xia F, Wang Q, Liao F, Guo Q, Xu C, Wang J. Discovery and repurposing of artemisinin. Front Med 2022. [PMID: 35290595 DOI: 10.1007/s11684-021-0898-6] [Reference Citation Analysis]
302 Ruscitti P, Bruno F, Berardicurti O, Acanfora C, Pavlych V, Palumbo P, Conforti A, Carubbi F, Di Cola I, Di Benedetto P, Cipriani P, Grassi D, Masciocchi C, Iagnocco A, Barile A, Giacomelli R. Response to: 'Correspondence on 'Lung involvement in macrophage activation syndrome and severe COVID-19: results from a cross-sectional study to assess clinical, laboratory and artificial intelligence-radiological differences' by Ruscitti et al' by Chen et al. Ann Rheum Dis 2020:annrheumdis-2020-218909. [PMID: 32907802 DOI: 10.1136/annrheumdis-2020-218909] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
303 Tan YL, Tan KSW, Chu JJH, Chow VT. Combination Treatment With Remdesivir and Ivermectin Exerts Highly Synergistic and Potent Antiviral Activity Against Murine Coronavirus Infection. Front Cell Infect Microbiol 2021;11:700502. [PMID: 34395311 DOI: 10.3389/fcimb.2021.700502] [Reference Citation Analysis]
304 Evangelou K, Veroutis D, Paschalaki K, Foukas PG, Lagopati N, Dimitriou M, Papaspyropoulos A, Konda B, Hazapis O, Polyzou A, Havaki S, Kotsinas A, Kittas C, Tzioufas AG, de Leval L, Vassilakos D, Tsiodras S, Stripp BR, Papantonis A, Blandino G, Karakasiliotis I, Barnes PJ, Gorgoulis VG. Pulmonary infection by SARS-CoV-2 induces senescence accompanied by an inflammatory phenotype in severe COVID-19: possible implications for viral mutagenesis. Eur Respir J 2022:2102951. [PMID: 35086840 DOI: 10.1183/13993003.02951-2021] [Reference Citation Analysis]
305 Lanzoni G, Linetsky E, Correa D, Messinger Cayetano S, Alvarez RA, Kouroupis D, Alvarez Gil A, Poggioli R, Ruiz P, Marttos AC, Hirani K, Bell CA, Kusack H, Rafkin L, Baidal D, Pastewski A, Gawri K, Leñero C, Mantero AMA, Metalonis SW, Wang X, Roque L, Masters B, Kenyon NS, Ginzburg E, Xu X, Tan J, Caplan AI, Glassberg MK, Alejandro R, Ricordi C. Umbilical cord mesenchymal stem cells for COVID-19 acute respiratory distress syndrome: A double-blind, phase 1/2a, randomized controlled trial. Stem Cells Transl Med 2021;10:660-73. [PMID: 33400390 DOI: 10.1002/sctm.20-0472] [Cited by in Crossref: 26] [Cited by in F6Publishing: 48] [Article Influence: 26.0] [Reference Citation Analysis]
306 Linares C, Culqui D, Belda F, López-Bueno JA, Luna Y, Sánchez-Martínez G, Hervella B, Díaz J. Impact of environmental factors and Sahara dust intrusions on incidence and severity of COVID-19 disease in Spain. Effect in the first and second pandemic waves. Environ Sci Pollut Res Int 2021. [PMID: 33993402 DOI: 10.1007/s11356-021-14228-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
307 Omoush SA, Alzyoud JAM. The Prevalence and Impact of Coinfection and Superinfection on the Severity and Outcome of COVID-19 Infection: An Updated Literature Review. Pathogens 2022;11:445. [DOI: 10.3390/pathogens11040445] [Reference Citation Analysis]
308 Laurini E, Marson D, Aulic S, Fermeglia A, Pricl S. Molecular rationale for SARS-CoV-2 spike circulating mutations able to escape bamlanivimab and etesevimab monoclonal antibodies. Sci Rep 2021;11:20274. [PMID: 34642465 DOI: 10.1038/s41598-021-99827-3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
309 Levi-Schaffer F, de Marco A. Coronavirus disease 2019 and the revival of passive immunization: Antibody therapy for inhibiting severe acute respiratory syndrome coronavirus 2 and preventing host cell infection: IUPHAR review: 31. Br J Pharmacol 2021;178:3359-72. [PMID: 33401333 DOI: 10.1111/bph.15359] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
310 Schoeman D, Fielding BC. Human Coronaviruses: Counteracting the Damage by Storm. Viruses 2021;13:1457. [PMID: 34452323 DOI: 10.3390/v13081457] [Reference Citation Analysis]
311 Rahaman SM, Chowdhury B, Acharjee A, Singh B, Saha B. Surfactant-based therapy against COVID-19: A review. Tenside Surfactants Detergents 2021;58:410-5. [DOI: 10.1515/tsd-2021-2382] [Reference Citation Analysis]
312 Jamaati H, Hashemian SM, Farzanegan B, Malekmohammad M, Tabarsi P, Marjani M, Moniri A, Abtahian Z, Haseli S, Mortaz E, Dastan A, Mohamadnia A, Vahedi A, Monjazebi F, Yassari F, Fadaeizadeh L, Saffaei A, Dastan F. No clinical benefit of high dose corticosteroid administration in patients with COVID-19: A preliminary report of a randomized clinical trial. Eur J Pharmacol 2021;897:173947. [PMID: 33607104 DOI: 10.1016/j.ejphar.2021.173947] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 9.0] [Reference Citation Analysis]
313 Almutairi AS, Abunurah H, Hadi Alanazi A, Alenazi F, Nagy H, Saad Almutairi N, Wells M, Alawam A, Alqahtani MM. The immunological response among COVID-19 patients with acute respiratory distress syndrome. J Infect Public Health 2021;14:954-9. [PMID: 34130119 DOI: 10.1016/j.jiph.2021.05.007] [Reference Citation Analysis]
314 Karampoor S, Hesamizadeh K, Shams Z, Ghafari Novin A, Farahmand M, Zahednasab H, Mirzaei R, Zamani F, Hajibaba M, Bouzari B, Laali A, Tabibzadeh A, Hadi Karbalaie Niya M, Keyvani H. The role of lovastatin in the attenuation of COVID-19. Int Immunopharmacol 2021;101:108192. [PMID: 34607230 DOI: 10.1016/j.intimp.2021.108192] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
315 Alrashed F, Battat R, Abdullah I, Charabaty A, Shehab M. Impact of medical therapies for inflammatory bowel disease on the severity of COVID-19: a systematic review and meta-analysis. BMJ Open Gastroenterol 2021;8:e000774. [PMID: 34725056 DOI: 10.1136/bmjgast-2021-000774] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
316 Tran VL, Parsons S, Nuibe A. The Trilogy of SARS-CoV-2 in Pediatrics (Part 2): Multisystem Inflammatory Syndrome in Children. J Pediatr Pharmacol Ther 2021;26:318-38. [PMID: 34035676 DOI: 10.5863/1551-6776-26.4.318] [Reference Citation Analysis]
317 Generali M, Kehl D, Wanner D, Okoniewski MJ, Hoerstrup SP, Cinelli P. Heterogeneous expression of ACE2 and TMPRRS2 in mesenchymal stromal cells. J Cell Mol Med 2021. [PMID: 34821008 DOI: 10.1111/jcmm.17048] [Reference Citation Analysis]
318 Baranwal M, Gupta Y, Dey P, Majaw S. Antiinflammatory phytochemicals against virus-induced hyperinflammatory responses: Scope, rationale, application, and limitations. Phytother Res 2021;35:6148-69. [PMID: 34816512 DOI: 10.1002/ptr.7222] [Reference Citation Analysis]
319 Johnson AM, Barigye R, Saminathan H. Perspectives on the use and risk of adverse events associated with cytokine-storm targeting antibodies and challenges associated with development of novel monoclonal antibodies for the treatment of COVID-19 clinical cases. Hum Vaccin Immunother 2021;17:2824-40. [PMID: 33974497 DOI: 10.1080/21645515.2021.1908060] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
320 Kim CW, Aronow WS. COVID-19, cardiovascular diseases and cardiac troponins. Future Cardiol 2021. [PMID: 34476978 DOI: 10.2217/fca-2021-0054] [Reference Citation Analysis]
321 Arabi YM, Jawdat D, Hajeer AH, Sadat M, Jose J, Vishwakarma RK, Almashaqbeh W, Al-Dawood A. Inflammatory Response and Phenotyping in Severe Acute Respiratory Infection From the Middle East Respiratory Syndrome Coronavirus and Other Etiologies. Crit Care Med 2021;49:228-39. [PMID: 33181590 DOI: 10.1097/CCM.0000000000004724] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
322 Woodruff MC, Ramonell RP, Nguyen DC, Cashman KS, Saini AS, Haddad NS, Ley AM, Kyu S, Howell JC, Ozturk T, Lee S, Suryadevara N, Case JB, Bugrovsky R, Chen W, Estrada J, Morrison-Porter A, Derrico A, Anam FA, Sharma M, Wu HM, Le SN, Jenks SA, Tipton CM, Staitieh B, Daiss JL, Ghosn E, Diamond MS, Carnahan RH, Crowe JE Jr, Hu WT, Lee FE, Sanz I. Extrafollicular B cell responses correlate with neutralizing antibodies and morbidity in COVID-19. Nat Immunol 2020;21:1506-16. [PMID: 33028979 DOI: 10.1038/s41590-020-00814-z] [Cited by in Crossref: 137] [Cited by in F6Publishing: 139] [Article Influence: 68.5] [Reference Citation Analysis]
323 Zibaeenezhad MJ, Moaref A, Abtahi F, Moghadami M, Johari MK, Ardekani A, Keshavarz M. Left ventricular thrombosis and endogenous endophthalmitis in the setting of COVID‐19: A case report. Clinical Case Reports 2022;10. [DOI: 10.1002/ccr3.5821] [Reference Citation Analysis]
324 Ning L, Abagna HB, Jiang Q, Liu S, Huang J. Development and application of therapeutic antibodies against COVID-19. Int J Biol Sci 2021;17:1486-96. [PMID: 33907512 DOI: 10.7150/ijbs.59149] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
325 Chourasia M, Koppula PR, Battu A, Ouseph MM, Singh AK. EGCG, a Green Tea Catechin, as a Potential Therapeutic Agent for Symptomatic and Asymptomatic SARS-CoV-2 Infection. Molecules. 2021;26. [PMID: 33668085 DOI: 10.3390/molecules26051200] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
326 Rawat S, Vrati S, Banerjee A. Neutrophils at the crossroads of acute viral infections and severity. Mol Aspects Med 2021;:100996. [PMID: 34284874 DOI: 10.1016/j.mam.2021.100996] [Reference Citation Analysis]
327 Bösch S, Westerman L, Renshaw N, Pravst I. Trans Fat Free by 2023-A Building Block of the COVID-19 Response. Front Nutr 2021;8:645750. [PMID: 33859993 DOI: 10.3389/fnut.2021.645750] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
328 Wan Afifudeen CL, Teh KY, Cha TS. Bioprospecting of microalgae metabolites against cytokine storm syndrome during COVID-19. Mol Biol Rep 2021. [PMID: 34751914 DOI: 10.1007/s11033-021-06903-y] [Reference Citation Analysis]
329 Kao M, Yang J, Balasubramaniam A, Traisaeng S, Jackson Yang A, Yang JJ, Salamon BP, Herr DR, Huang C. Colonization of nasal cavities by Staphylococcus epidermidis mitigates SARS‐CoV‐2 nucleocapsid phosphoprotein‐induced interleukin (IL)‐6 in the lung. Microbial Biotechnology. [DOI: 10.1111/1751-7915.13994] [Reference Citation Analysis]
330 Ali H, Alterki A, Sindhu S, Alahmad B, Hammad M, Al-Sabah S, Alghounaim M, Jamal MH, Aldei A, Mairza MJ, Husain M, Deverajan S, Ahmad R, Cherian P, Alkhairi I, Alkandari A, Abubaker J, Abu-Farha M, Al-Mulla F. Robust Antibody Levels in Both Diabetic and Non-Diabetic Individuals After BNT162b2 mRNA COVID-19 Vaccination. Front Immunol 2021;12:752233. [PMID: 34899701 DOI: 10.3389/fimmu.2021.752233] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
331 Alfadda AA, AlKhowaiter M, Alotaibi N, Alayed K, Alzahrani M, Binkhamis K, Siddiqui K, Youssef A, Altalhi H, Almaghlouth I, Alarifi M, Albanyan S, Alosaimi MF, Hasanato R, Isnani A, Dekhil H, Rafiullah M. Clinical and biochemical characteristics and outcomes of suspected COVID-19 hospitalized patients: RT-PCR swab positive and negative comparison. J Infect Public Health 2021;14:1623-9. [PMID: 34624717 DOI: 10.1016/j.jiph.2021.09.014] [Reference Citation Analysis]
332 Nair A, Sharma P, Tiwary MK. Glutathione deficiency in COVID19 illness-does supplementation help? Saudi J Anaesth 2021;15:458-60. [PMID: 34658741 DOI: 10.4103/sja.sja_320_21] [Reference Citation Analysis]
333 Mehboob R, Lavezzi AM. Neuropathological explanation of minimal COVID-19 infection rate in newborns, infants and children - a mystery so far. New insight into the role of Substance P. J Neurol Sci 2021;420:117276. [PMID: 33360484 DOI: 10.1016/j.jns.2020.117276] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
334 Prasad S, Patel S, Behera AK, Gitismita N, Shah S, Nanda R, Mohapatra E. Early Biochemical Markers in Predicting the Clinical Outcome of COVID-19 Patients Admitted in Tertiary Care Hospital in Chhattisgarh, India. J Lab Physicians. [DOI: 10.1055/s-0042-1742631] [Reference Citation Analysis]
335 Ealey KN, Phillips J, Sung HK. COVID-19 and obesity: fighting two pandemics with intermittent fasting. Trends Endocrinol Metab 2021;32:706-20. [PMID: 34275726 DOI: 10.1016/j.tem.2021.06.004] [Reference Citation Analysis]
336 Charzewski Ł, Krzyśko KA, Lesyng B. Structural characterisation of inhibitory and non-inhibitory MMP-9-TIMP-1 complexes and implications for regulatory mechanisms of MMP-9. Sci Rep 2021;11:13376. [PMID: 34183752 DOI: 10.1038/s41598-021-92881-x] [Reference Citation Analysis]
337 da Rocha AP, Atallah AN, Aldrighi JM, Pires ALR, Dos Santos Puga ME, Pinto ACPN. Insufficient evidence for vitamin D use in COVID-19: A rapid systematic review. Int J Clin Pract 2021;:e14649. [PMID: 34310814 DOI: 10.1111/ijcp.14649] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
338 Choi JH, Lee YH, Kwon TW, Ko S, Nah S, Cho I. Can Panax ginseng help control cytokine storm in COVID-19? Journal of Ginseng Research 2022. [DOI: 10.1016/j.jgr.2022.02.006] [Reference Citation Analysis]
339 Bae M, Kim H. Mini-Review on the Roles of Vitamin C, Vitamin D, and Selenium in the Immune System against COVID-19.Molecules. 2020;25. [PMID: 33207753 DOI: 10.3390/molecules25225346] [Cited by in Crossref: 34] [Cited by in F6Publishing: 26] [Article Influence: 17.0] [Reference Citation Analysis]
340 Tang H, Bohannon L, Lew M, Jensen D, Jung SH, Zhao A, Sung AD, Wischmeyer PE. Randomised, double-blind, placebo-controlled trial of Probiotics To Eliminate COVID-19 Transmission in Exposed Household Contacts (PROTECT-EHC): a clinical trial protocol. BMJ Open 2021;11:e047069. [PMID: 33952552 DOI: 10.1136/bmjopen-2020-047069] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
341 Taha SI, Shata AK, Baioumy SA, Fouad SH, Anis SG, Mossad IM, Moustafa NM, Abdou DM, Youssef MK. Toll-Like Receptor 4 Polymorphisms (896A/G and 1196C/T) as an Indicator of COVID-19 Severity in a Convenience Sample of Egyptian Patients. J Inflamm Res 2021;14:6293-303. [PMID: 34866927 DOI: 10.2147/JIR.S343246] [Reference Citation Analysis]
342 Zhang M, Ye L, Cheng C, Shen F, Niu L, Hou Y, Bai G. Dietary Flavone Baicalein Combinate with Genipin Attenuates Inflammation Stimulated by Lipopolysaccharide in RAW264.7 Cells or Pseudomonas aeruginosa in Mice via Regulating the Expression and Phosphorylation of AKT. Nutrients 2021;13:4462. [PMID: 34960014 DOI: 10.3390/nu13124462] [Reference Citation Analysis]
343 Gudowska-sawczuk M, Mroczko B. What Is Currently Known about the Role of CXCL10 in SARS-CoV-2 Infection? IJMS 2022;23:3673. [DOI: 10.3390/ijms23073673] [Reference Citation Analysis]
344 Lim MS, Mcrae S. COVID-19 and immunothrombosis: Pathophysiology and therapeutic implications. Crit Rev Oncol Hematol 2021;168:103529. [PMID: 34800652 DOI: 10.1016/j.critrevonc.2021.103529] [Reference Citation Analysis]
345 Zhu Y, Geng S, Li Q, Jiang H. Transplantation of Mesenchymal Stem Cells: A Potential Adjuvant Therapy for COVID-19. Front Bioeng Biotechnol 2020;8:557652. [PMID: 33224928 DOI: 10.3389/fbioe.2020.557652] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
346 Veluswamy P, Wacker M, Stavridis D, Reichel T, Schmidt H, Scherner M, Wippermann J, Michels G. The SARS-CoV-2/Receptor Axis in Heart and Blood Vessels: A Crisp Update on COVID-19 Disease with Cardiovascular Complications. Viruses 2021;13:1346. [PMID: 34372552 DOI: 10.3390/v13071346] [Reference Citation Analysis]
347 Chegni H, Babaii H, Hassan ZM, Pourshaban M. Immune response and cytokine storm in SARS-CoV-2 infection: Risk factors, ways of control and treatment. Eur J Inflamm 2022;20:1721727X2210989. [DOI: 10.1177/1721727x221098970] [Reference Citation Analysis]
348 Andrade FB, Gualberto A, Rezende C, Percegoni N, Gameiro J, Hottz ED. The Weight of Obesity in Immunity from Influenza to COVID-19. Front Cell Infect Microbiol 2021;11:638852. [PMID: 33816341 DOI: 10.3389/fcimb.2021.638852] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
349 Casillas Santana MA, Arreguín Cano JA, Dib Kanán A, Dipp Velázquez FA, Munguía PDCS, Martínez Castañón GA, Castillo Silva BE, Sámano Valencia C, Salas Orozco MF. Should We Be Concerned about the Association of Diabetes Mellitus and Periodontal Disease in the Risk of Infection by SARS-CoV-2? A Systematic Review and Hypothesis. Medicina (Kaunas) 2021;57:493. [PMID: 34068221 DOI: 10.3390/medicina57050493] [Reference Citation Analysis]
350 Mehta Y, Mehta C, Nanda S, Kochar G, George JV, Singh MK. Use of CytoSorb therapy to treat critically ill coronavirus disease 2019 patients: a case series. J Med Case Rep 2021;15:476. [PMID: 34535189 DOI: 10.1186/s13256-021-03021-y] [Reference Citation Analysis]
351 Ibrahim S, Monaco GSF, Sims EK. Not so sweet and simple: impacts of SARS-CoV-2 on the β cell. Islets 2021;13:66-79. [PMID: 33970787 DOI: 10.1080/19382014.2021.1909970] [Reference Citation Analysis]
352 Ali FEM, Mohammedsaleh ZM, Ali MM, Ghogar OM. Impact of cytokine storm and systemic inflammation on liver impairment patients infected by SARS-CoV-2: Prospective therapeutic challenges. World J Gastroenterol 2021; 27(15): 1531-1552 [PMID: 33958841 DOI: 10.3748/wjg.v27.i15.1531] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]